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ABSTRACT
TITLE: Prospective randomised controlled trial to assess the effect of  normal saline wound
irrigation in reducing surgical site infection after elective open colorectal resections
DEPARTMENT: GENERAL SURGERY
DEGREE & SUBJECT: MS GENERAL SURGERY
NAME OF THE CANDIDATE: DR. AUGUSTIN ABRAHAM. T
NAME OF THE GUIDE: DR. MARK RANJAN JESUDASON
OBJECTIVES
1.To compare the rate of abdominal incisional surgical site infection in the study arm –normal
saline wound irrigation with that in the control arm, no wound irrigation, in all the open elective
colorectal resections in General surgery unit 2.
2. To identify other risk factors for surgical site infection.
METHODS
This is a randomised double blinded controlled trial. Patients undergoing elective colorectal
resection were recruited as per the inclusion and exclusion criteria after informed consent and
randomly allocated to either the study arm (receiving normal saline wound wash) or the
control arm (receiving no wound wash). The surgical wound was inspected periodically until
30 days after the operation.  Data was entered in epidata spreadsheet. Chi-square test, the test
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of significance was used to compare the two groups. Also Chi-square values of the other risk
factors were calculated and analysed using SSPS software version 17.  Risk factors with p
value less than 0.05 were considered significant.
RESULTS:
There was no statistically significant difference in the incidence of incisional surgical site
infection between the two arms. None of the other factors that were studied had any
association with incisional surgical site infection.
Conclusion:
There is no significant benefit from washing the surgical wound with normal saline before
skin closure in preventing SSI in the patients undergoing elective colorectal operations.
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Randomised controlled trial to assess
the effect of normal saline wound
irrigation in reducing surgical site
infection after elective open
colorectal resections
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INTRODUCTION
Surgical site infection:
Surgical site infection (SSI) is a common cause of morbidity and prolonged hospital stay
among patients undergoing surgical operations.It decreases the health associated quality of
life and increases the risk of mortality.(1)(2)(3)It is a leading risk factor for readmission
during the first 30 days after hospital discharge.It increases the hospital expenses
significantly.(2)(4) In addition to causing harm to the patient, SSI increases the health care
expenses by increasing the length of hospital stay, doctor visits, dressings and home care. So
SSI results in an increased burden not only on the patient but also on the health care giver.
This also increases the overall cost of hospitalisation.
SSI constitutes an important goal of improvement in surgical care. It is being used as a good
indicator of quality of surgical care provided in an institution.(5) Infections following an
operation are definitely preventable to a certain extent. There are multiple pre operative, intra
operative and post operative factors which can influence the development of incisional
surgical site infection.
The following is a summary of preventive measures recommended according to NICE
guidelines(6)for prevention and management of surgical site infections.
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Preoperative phase:
 Preoperative showering is advised using soap.  This can be done prior to the operation
or the day of the planned procedure.
 The removal of hair in the surgical site is routinely avoided.  This is done to avoid
infection at the operated site. The use of razors is not recommended as this can
increase incidence of infection.  Electric clippers can be used safely if hair reoval is
necessary on the day of the surgery.
 Appropriate theatre clothes is also mandatory for all health care professionals..
 Any health care giver who is inside the operation theatre should wear the required
sterile/unsterile theatre attire. The movement of staff within theatre premises should
be minimal and confined only to the essential staff.
 Mechanical bowel preparation and nasal decontamination are avoided
 Appropriate antibiotic prophylaxis as per local antibiotic resistance pattern is required
in the following settings:
o Clean operation where an artificial prosthesis or an implant is used, for
example – hernia surgery.
o Clean-contaminated operation and
o Contaminated operation
 Clean operations where prosthesis is not used and are of short duration the routine use
of antibiotics is not advised. Before giving antibiotic prophylaxis, the timing(within
60 minutes of the skin incision) and pharmacokinetics (for example, the serum half-
life) and necessary infusion time of the antibiotic should be considered. A dose of
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antibiotic prophylaxis should be repeated when the operation duration is prolonged. In
setting of dirty wounds and infected wounds therapeutic antibiotics is recommended.
Intraoperative phase:
 Hand decontamination before the operation.  This can be done using an alcohol based
hand rub or an antiseptic solution.
 Incise drapes which are non-iodophor should not be used since they might increase
the chance of infection.
 Antiseptic skin preparation, preferably alcohol based Chlorhexidine in non-mucosal
areas. However, it is still controversial as to which of the antiseptic solution is better
than the other.
 Surgical incisions are preferably made with skin knives as diathermy use can
predispose to surgical site infection.
 Inadvertentperioperative hypothermia should be avoided
 Optimaloxygenation and adequate perfusion during surgery have to be maintained.
 Wound irrigation and intracavity lavage are avoided.
Post operative phase:
If we consider that a patient has wound infection in the surgical site post operatively,
antibiotic that covers the likely causative organism is used. Debridement is done if required.
In colorectal resections, there is high morbidity and mortality related to surgical site
infections. It is the practice of the surgeons to irrigate with normal saline in wound of patients
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who are likely to develop surgical site infections. There are two studies(7)(8) done comparing
the rate of surgical site infection when the surgical wound is irrigated  and when not.These
were done in patients undergoing gynecological and general surgical operations. There is no
study among patients who have electively undergone colorectal surgeries. Therefore, there is
a need for a study to show that normal saline wound irrigation decresases the risk of
abdominal SSI following colorectal operations.
Hence, through this research trial, it was planned compare the incidence of abdominal
surgical site infection after colorectal resections in the post operative period between the
group receiving wound irrigation with normal saline and the group receiving no wound
irrigation.
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AIM:
To assess the effect of normal saline wound irrigation in reducing the surgical site infection
after elective colorectal resections.
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OBJECTIVES:
1. To compare the rate of abdominal incisional surgical site infection in the study arm –
normal saline wound irrigation with that in the control arm, no wound irrigation, in all
the open elective colorectal resections in General surgery unit 2.
2. To identify other risk factors for surgical site infection
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Definition of surgical site infection:
The standard definition of surgical site infections (SSIs) that we have used is provided by the
Centre for Disease Control.  This was published in the year 1992 and was updated
subsequently in 2003. According to the guideline layed out, SSIs are divided into two entities
– incisional infection and infections involving organ space or deep infections(9)(10)
Incisional SSIs are divided into 2 categories: superficial infection, which includes skin and
the underlying subcutaneous tissue.  Involvement of the muscle and fascia is categorised as
deep infections.  Dividing surgical infections into the above mentioned categories is vital as
the aetiology and management of both these entities are different and the prognosis is also
different. (11).
Both the categories involve infection occurring within a month of the procedure and upto a
year if an artificial prosthesis was used during the operation.
Superficial incisional surgical site infection diagnostic criteria:
Infection  that is confined to the skin and underlying tissue (sub-cutaneous) and having at
least one of the following –
 Pus discharge which may or may not be confirmed using the laboratory.
 Clinical parameters:
 Increased pain
 Tenderness
 Swelling of tissues
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 Erythema
 Increased warmth
 Superficial incision deliberately opened by surgeon
 Diagnosis is made by the attending physician.
Deep incisional surgical site infection:
 This is diagnosed when there is infection of the deeper structures, this includes fascia
and muscles and one of the following:
 Pus discharge from the muscles or fascia without organ space infection.
.
 Spontaneous breakdown of the deeper incisional space or if deliberately
opened by a physician when infection is suspected.
 Pus discharge suggestive of an abscess is found on
 Clinical examination, during an operative procedure, proven in the
histopathology lab or if there is radiological evidence of the same.
 Diagnosis made by the physician during ward rounds..
Organ space surgical site infection:
 This entity is reserved to diagnose an infection of a space/organ that is
infected as a result of the procedure.  This does not include the previously
mentioned entities.  The following inclusion details have to be met-
 Murky fluid or pus discharge in the drain which has been placed in the organ
space.
 Presence of an organism which is confirmed by microbiological examination.
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 An abscess involving the organ or space which is diagnosed either clinically,
during a procedure such as re-operation or with the assistance of radiological
imaging..
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Epidemiology of surgical site infection:
The incidence of surgical site infection in patients undergoing a major operation in United
States is about 2-5% each year.(12)(13)The risk of having an infection at the operated site is
different for operations at different anatomical locations .
Operations of face, neck and head for cosmesis pose a much lower risk of SSI than operation
in the lower GI tract for example colon resection.  Malignancy, increased age and comorbid
illnesse further complicate the scenario.
An elective operation has lower SSI rate than do an emergency operation.
Rate of surgical site infections (SSIs) for various procedures also differ based on the
population, size of the hospital, experience of the operating surgeon and methods used for
monitoring and surveillance. Non-teaching hospitals usually have the low rates of SSI
compared to teaching hospitals (4.6 versus 8.2 percent, respectively).(14) Oncological
operations have increased incidence of having infections.  This is reported in a few studies.
(15)
Stratification of different operations into classes (that have similar risks for infection) is vital,
so that
1. Preventive methods can be appropriately planned among similar individuals and
2. When infection rates differ from accepted international trends, quality monitors can
be implemented.
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Classification of surgical wounds:
A surgical wound can be classified as clean, clean contaminated, contaminated or dirty based
on amount of bacterial load in the surgical site during operation.(16)
Class I/Clean:
No inflammation.
Alimentary tract is not entered
Respiratory tract is not entered
Genital or urinary tractis not entered.
Clean wounds are closed primarily.
Class II/Clean-
Contaminated:
If there is no inflammation or infection.
If the bowel(alimentary tract), respiratory tract or the urogenital
system is entered in a planned and prepared manner then they are
classified as clean contaminated wounds.
Class
III/Contaminated:
Fresh, open wounds
Break in the asepsis protocol
GIT contents spillage
Entry into the body cavities when there is infection
Incisions where acute inflammation( non-purulent) is encountered are
included in this class
.
Class IV/Dirty-
Infected
Devitalised tissue
Faecal contamination
Dirty wounds and open traumatic wounds.
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Stratification of risk for SSI:
Recognized factors associated with SSI are necessary to stratify patient's risk and to design
prevention strategies. Surgical wounds were stratified in 1964 based on the landmark
publication in 1964 by The National Academy of Sciences–National Research Council.
(17)Wounds were classified based on endogenous bacterial contamination.  There was non-
controversial evidence to suggest that wound stratification is necessary.  This allowed for
comparability of wounds between hospitals, services and time periods.
The operation site, operative time and the clinical status of the patient were identified as the
risk factors for wound infection as defined in 1980s by SENIC. (18)
The  surgical duration, wound classification and ASA classification greater than 2 were risk
factors for wound infection as defined by National Nosocomial Infection Surveillance
(NNIS).(19) These risk factors or categorization can also be used outside the United  States of
America. (20)
The use of laparoscopy for GI operations specially colorectal operations was added to the
above mentioned three risk factors. This model was published in 2010 and was incorporated
with the CDC risk factors for wound infection(21)
The major drawback with the SENIC and NNIS assessments was that they did not include
factors such as smoking, glycemic control, body temperature and tissue oxygenation.  All
these factors are difficult to monitor and although they definitely affect clinical outcomes,
they are statistically difficult to measure.
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P.Gervaz et al published a simple clinical scoring system based on four variables. This
system is based on four preoperative clinical  parameters – contamination, obesity,
laparotomy and ASA grade (COLA) and was constructed so as to help to identify patients at
high risk of developing SSI after colorectal resection.(23)
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Prevention of SSIs :
Surgical site infections are presumably preventable. There are multiple risk factors and
prevention strategies in controlling surgical site infections. Each of these factors has to be
taken into consideration and appropriate methods need applied to prevent surgical site
infection so that the preventable morbidity of any operation can be reduced.
Historical Perspective(24)
Historically, example of surgical wound care is seen in the battlefield.  Gunshot wounds were
managed with a cocktail of rose oil, moss from mummy’ skull and worms. Ambroise’s use of
mixture of cold turpentine, yolk from eggs and rose oil was heralded as a milestone. Inspite
of the efficacy of hand hygiene in reducing puerperal sepsis being proved by Semmelweis in
the mid-1800s and later popularized by Holmes, hand-washing by surgeons was not
established as common practice till early 20th century.
Major operations were almost always followed by infective complications, manifesting as
cellulitis lastly progressive soft tissue infections and tetanus with a high mortality rate. In
1867 Joseph lister introduced carbolic sprays to disinfect the surgeon, the operation theatre
and the patient.  This caused a dramatic reduction in infection rates to less than 10 percent.
The concept of asepsis was initially not universally accepted but Lister’s results created a
case to accept Pasteur's theory that purulence was caused by microorganisms by process of
putrefaction. After adopting hand-washing and the use of autoclaved sterile gowns, gloves
and supplies, infection rates for clean operations approached close to modern rates. But, GI
operations still carried high incidence of infection as the organism was endogenous in origin.
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Early clinical studies done in the 1950s revealed that there was no benefit or an increase in
the wound infection rates after the introduction of routine antibiotics.  There was also the fear
of resistant strains developing.(25)(26)(27)
This apparent failure of antibiotic prophylaxis was fallacious and Burke et al in 1960 showed
a flaw in the previous studies.  He administered a single dose of antibiotic at various times
and concluded that the delay in antibiotic administration was the reason for failure of
prophylaxis.  If antibiotics were administered before 3 hours of the procedure they were as
good as not administering antibiotics at all.  He therefore highlighted the importance of
timing of antibiotic prophylaxis.
An infection in the surgical site arises as a result of inoculation with a higher bacterial load
than the body can contain.(29) Therefore, dirty wounds and immunosuppression increased
incidence of SSI.
This is true specially in colorectal surgery as there is a higher bacterial load that has to be
overcome.
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The risk factors studied in the development of SSI are the following:
Pre-operative
Intra-operative
Post-operative
The following pre-operative risk factors have been identified –
Age,
Gender,
Diabetes mellitus, Airway disease such as COPD,
Heart ailments,
Chronic liver disease,
Steroid or immunosuppressive drugs,
Body mass index (BMI),
Nutrition status of the patient
Anemia
Colorectal pathological diagnosis which involves the stage of the disease and presence or
absence of neoadjuvant radiation and chemo therapy.(30)
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Intraoperative and postoperative factors that can influence arethe following:
Emergency operation,
Colorectal resection type (eg. Right hemicolectomy vs low anterior resection),
Multivisceral resection,
Ostomy creation (ileostomy or colostomy),
Duration of the procedure
Postoperative ICU care,
Blood transfusion (30)
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Determinants of infection:
Risk assessments integrate thethree determinants of infection: bacteria, local environment
(i.e) the surgical site and systemic host (patient)defenses(22)
In a homeostatic state,the surgical site, bacteriaand hostdefence mechanisms
(represented by three circles) intersect at apoint indicating zero probability of sepsis(22)
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BACTERIA
The influence of bacteria on surgical site infection can be studied in four major components:
the bacterial inoculum, the pathogenicity of organisms, source of bacteria and bacterial
properties.
BACTERIAL INOCULUM
Most of what is known about bacteria is put to use, in major efforts directed at reducing their
numbers by means of asepsis and antisepsis. Without an infecting agent, no infection will
result. The infectivity of an organism is based on the size of the bacterial inoculum. Wounds
are classified according to whether the inoculum of bacteria in the wound is likely to be large
enough to overcome local and systemic defence mechanisms of the host and thus result in
infection. According to one study, the number of bacteria present in the wound at the end of
an operation was the most important factor in the development of a surgical site
infection.(31) Another study quantitated this and explained how local environmental factors
might be integrated in knowing and understanding .(32) In the era before prophylactic
antibiotics were used, as well as during the early phases of antibiotic use, there was a close
relation between the classification of the surgical wound (which is based on the probability of
a significant inoculum) and the rate of surgical site infection.(17)(33) This relation is still
important and other risk factors have been also found to play a major role.(18)(34)
SOURCES OF BACTERIA
Endogenous bacteria which are present in colonies have been found to be major cause of SSI
than exogenous bacteria. In clean - contaminated, contaminated and dirty/already infected
surgical wounds, the source and the number of bacteria present are functions of the patient’s
clinical condition and the specific organs which are being operated. Infected operations are
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those in which pus and infected tissue are drained or removed, and bacterial inoculum is
already present in the surgical site. The inoculums of the organism may be as high as 1010
bacteria/ml, some of which may already be causing an infection.  Also, some organism will
be in the growth phase rather than the lag or the dormant phase and so could be more
pathogenic. When the wound is heavily contaminated, it is best managed by delayed primary
closure. This ensures that the wound which is almost certain to develop a wound infection is
not allowed to close over a bacterial inoculum.
When remote infection is present, patients should not undergo an elective operation since it is
associated with an increased incidence of wound infection.(17) In patients having UTI,
surgical wounds frequently become infected with the same micro-organism.  Remote
infections must be treated appropriately and the operation should be planned on a later date.
If the operation can’t be delayed to another appropriate day, prophylactic or therapeutic
antibiotics are recommended.
Control of sources of bacteria:
Preoperative methods of reducing patient flora (especially reducing endogenous bacteria) are
of major concern e.g. Mechanical bowel preparation, antimicrobial baths and preoperative
hair removal causing trauma to the shaved areas and the small areas of inflammation and
infection becomes inevitable.
If hair removal is needed, clipping rather than shaving, is preferably done in the operation
room just before the operative procedure (35)(36).
In the recent past, the role of the classic bowel preparation has been controversial.
(37)(38)(39)(40)(41)
When infection develops after clean operations, particularly those in which implants are
placed, the skin is the most important source of the infecting bacteria though endogenous
organisms may also be involved occasionally. Operating room (OR) personnel are the most
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important source of exogenous bacteria.(42)(43)(44) Both the operating team—surgeon,
assistants, nurses, and anaesthetists—and OR air were reported as important sources of
bacteria.
In a study done by the National Academy of Sciences–National Research Council, in 1964
ultraviolet light was efficacious only in the limited situations of clean and ultraclean cases.5.
There were minimal numbers of endogenous bacteria, and ultraviolet light controlled one of
the exogenous sources. It is possible to get good results in clean cases with implants without
using UVL systems.  However, clean air systems are here to stay. Nevertheless, the presence
of a clean air system does not mean that basic principles of asepsis and antisepsis should be
abandoned, because endogenous bacteria must still be controlled.
The use of drapes and gowns which are impermeable may therefore be of clinical importance
since bacteria can’t penetrate impermeable gown and drapes and hence they cannot gain entry
to the wound. (45)(46)
Chance of contamination
The chance of contamination is largely depending upon various other factors other than the
operation itself. The most prominent one is the  expected duration of the operative procedure,
which has been significantly associated with the surgical site infection rate.(18)(31)(33) The
longer the operation is, the more bacterial accumulation in the surgical wound from the
operating team, operating room, instruments and the patient himself. Another risk factor
which is not seen in the NNIS risk assessment is an abdominal operation.(18)(19) which
involves bacterial contamination. This is because maximum concentrations of endogenous
bacteria are located in the abdomen.
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BACTERIAL PROPERTIES
Apart from bacterial inoculums, virulence and pathogenicity of the bacteria are also
important. The gram-positive cocci are the most pathogenic bacteria in surgical patients are
gram-positive cocci e.g., Staphylococcus aureus and Streptococci.
The preoperative hospital stay has been found frequently to be an important factor to surgical
site infection rates.(33) Therefore, multiple factors combine to change the preoperative
patient who is hospitalized into a susceptible individual. Same-day admission should
eliminate any bacterial impact associated with the preoperative hospital stay. Multi resistant
bacteria (e.g. MRSA, S. epidermidis, and VRE) can be related with significant SSI. SSIs
caused by resistant organisms or unusual pathogens need specific prophylaxis along with
surgical care..
PATHOGENIC ORGANISMS
With the exception of clean operations, surgical site infections are recognized as having a
polymicrobial cause, involving both aerobic and anaerobic organisms
(47)(48)(49)(50)(51)(52) Intra abdominal(organ or space) infections normally reflect the
micro-flora of the resected organ.(47)(48) Despite the frequency and prevalence of
endogenous anaerobes in surgical wound infections, the Centres for Disease Control and
Prevention guideline for the prevention of surgical site infection has recognized S. aureus,
coagulase-negative Staphylococci, Enterococcus species, Escherichia coli, Pseudomonas
aeruginosa and Enterobacter species as the most frequently isolated pathogens. (53)
Unfortunately, this view has been based on only two published reports that provided no
indication of the inclusion of anaerobic bacteriology in the associated studies, and hence the
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data may have been biased in favour of aerobic and facultative microorganisms.(21) In
contrast, Rotstein et al. (54)stressed the polymicrobial nature of almost all surgical infections
and commented that the critical importance of aerobic-anaerobic mixtures in these infections
had been given relatively little attention.
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SURGICAL SITE – (FACTORS RELATED TO THE WOUND AND
SURGICAL TECHNIQUE):
Factors related to the surgical site influence development of wound infection since they
usually affect the size of inoculum of bacteria which is needed for the development of an
infection. In case of a susceptible wound, even a smaller bacterial inoculum will result in
development of infection.
INFLUENCE OF SURGEONS ON LOCAL FACTORS
Surgeons affect almost all the local factors that contribute to the development of surgical site
infection.(22)Halsted is established the necessity for excellence in techniques in operation
room so as to prevent wound infection. His principles stressed on sharp dissection,
haemostasis, fine sutures and tissue handling. Ligature en masse, braided or big non-
absorbable suture material, dead tissue and seroma or hematoma creation should be avoided.
The size of the bacterial inoculum is also influenced by the presence of foreign body which
can increase the number of bacteria in a tissue logarithmically. The foreign material could be
dead tissue resulting from inappropriate use of cautery device or a suture, a pacemaker or a
graft.(22)
The wound hematocrit and antibiotic are the two factors which causes variations in the
inoculum of bacteria necessary for development of surgical site infection. Whn there is
haemorrhagic fluid is present is more than 8% and antibiotic is not (31) the rate of surgical
site infection was 20%. However, in the presence of a wound which is technically sound,even
without antibiotic, 1000 bacteria is needed to produce the same infection rate.(32) If
antibiotic is present, 105 to 106 bacteria are needed for the development of surgical site
infections.
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Drains
The usage of abdominal drains differs between surgeons. While a simple drain may function
as exit for drainage of abdominal fluid collection, it can also be an access for the bacteria to
enter the abdomen. However, a closed suction drain can decrease the rate of surgical site
infection.(55)
A meta-analysis from 2004 narrated the conclusions as follows:
1) After colorectal and hepatic resections with a primary gastrointestinal anastomosis and
following an appendicectomy for appendicitis at any stage,placement of drains must be
avoided and
2)In case of upper GI surgeries involving oesophagus/gastric resections, drains must be used.
Further RCTs are necessary to find out the importance of prophylactic drain placement for
operationss, mainly operations of the upper gastrointestinal tract.
Duration of Operation
It has been proven that,(18)(31)(33) wound contamination increases certainly with time.
Wounds can get dried up and they are altered and are made susceptible to surgical site
infection.
Electrocautery
There will be rise in the incidence of superficial wound infections with usage of electrical
cautery. However, when used properly to provide focussed coagulation or to cut tissues
which are under traction, there is no charring, less destruction of tissue and there will be less
incidence of SSI rate.(56)
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HOST DEFENCE MECHANISM (PATIENT FACTORS)
Local Blood Flow
Inadequate local perfusion leads to reduced levels of oxygen in the tissue and so require only
les quantity of bacteria to produce infection. These situations arise in a patient in shock and a
patient with peripheral arterial occlusive disease. This condition can be overcome by
providing supplemental oxygen during and after the operation. This will increase the
subcutaneous oxygen level (measured by TcPO2).(57)
Barrier Function
The most clinically feasible way of protecting bowel is early initiation of enteral feeding and
administering amino acid glutamine as nutritional support for enterocytes and colonocytes.
This can help damaged intestinal mucosa recover.
Advanced Age
During aging, changes that occur functionally and structurally leave the subcutaneous and
dermal tissues more vulnerable to SSI. Usually, these body changes are irreversible. Wound
infection rates rise with increasing aging up to 65 years of age, after which point the rate
seems to decline.(57)
Patient defence Mechanisms
The host’s body response to infection is usually to destroy it but it is inhibited by underlying
debilitating disease of the patient and other factors in the environment.
Host defence mechanisms are also affected by surgeon related factors and patient related
factors.
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Surgeon-related factors to improve a patient’s systemic responses to surgery are limited.
Operation must be carried out with minimal blood loss, maintenance of good amount of
intravascular volume, adequate oxygenation of the tissue with good perfusion and avoidance
of shock which will reduce trauma and thus decrease the secondary, unintended immunologic
effects caused by major operations.
Diabetes is another recognized risk factor of SSI. Good glycemic control during the operation
and post operatively, can reduce the incidence of wound infection significantly in a patient
who does not have diabetes mellitus and those who have diabetes mellitus. Other important
factors are to maintain good oxygenation of tissue and to maintain normal temperature.
Patient factors are different clinical conditions which are related to altered immune response
in patients. Advanced age, ASA scoring, intra operative blood transfusion and the use of
immunosuppressants like chemotherapy agents are related with a rise in the rate of wound
infection. Most of these risks can’t be changed; still, patient  selection for an appropriate
surgery, antibiotic prophylaxis and fine surgical methods can reduce the bacterial inoculums
and thus the incidence of SSI. Smoking causes rise in the rate of wound infection. Even a
short period of smoking cassation is of  help to the patientDrug therapy like NSAIDS can
influence patient  body defence mechanism.
Operations involving inhalational anaesthetics cause sudden rise in concentration of plasma
cortisol. High epidural anaesthesia can modify the steroid induced immune modulation which
attenuated the pituitary adrenal activation will be greatly attenuated.
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Integration of Determinants of Infection
Applying knowledge of these effects practically, the following 3 steps has to be maintained
1. One should keep the microbial contamination of the wound as much less as possible
through aseptic techniques and cleanliness, preparation of surgeon and patient for the
operation, pre operatively along with prophylactic antibiotics.
2. Keeping factors that can influence the surgical site in a manner by which they can get rid
the lodgement of microbes and thus give a surrounding not conducive for their multiplication
and growth.
3. To maintain host defence mechanisms in a condition that the microbial growth is checked
at all the time.  The above are the important factors influencing infection & need proper
application or avoidance appropriately on a day to day basis. Every year there is decrease, in
incidence of surgical site infection, whenever these are strictly applied.(22)
It is clear that the risk of wound infection can’t be inspected in relation to microbial control
alone. Patient factors also play a major role in maintaining microbial counts at lower levels
by aseptic technique and antibiotic prophylaxis.(22)Important patient factors are maintaining
oxygenation of tissue, blood volume and tissue perfusion.
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Preventing SSIs in colorectal operations
Elective colorectal operations are clean contaminated procedures. The post operative
complications of colorectal operations constitute a major burden on the morbidity apart from
the morbidity caused by the colorectal disease themselves.  Among the operations performed
for colorectal diseases, most of them are done for malignancy. About 80% of the colorectal
operations are done for malignancy.
The SSI rate is substantially higher in individuals undergoing colorectal operations. The
current incidence of wound infection in colorectal surgeries, ranges from 5 to 30%.(58)(59)
The gross variation in published incidence of wound infection is mainly due to different
definitions which are used for defining wound infection. The high incidence is primarily
because of the large amount of bacterial colonization present in the large bowel.  It is about
1011 –1012 microorganisms present in every milliliter of stool in the large intestine(60)
When wound infection occurs following a colonic operation, it can be expected that the
pathogenic organisms causing the wound infection is mainly those bacteria that contaminated
the incision during surgery. In almost all colonic operations, the most likely organisms to be
encountered are E. coli and Bacteroides fragilis. Other bacteria like Klebsiella and
Enterobacter species also contribute. There is highest bacterial density of the anaerobic
species such as B. fragilis found in the left colon, sigmoid colon and rectum but they are not
consistently cultured since these organisms are obligate anaerobes. Other organism
commonly found in colon are Enterococcus species are found commonly in the colon but
they do not cause SSI very frequently in immunocompetent host. Prior hospitalisations of
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patients or exposure to antibiotics results in alteration of their normal gut microflora and rare
gram negative bacteria can be expected. Serratia species, Pseudomonas species and even
Acinetobacter species. can be found in these later circumstances.
Staphylococcus aureus colonisataion occur in about 20% to 25% of patients in U.S and these
bacteria can be found in surgical site infection after colonic operation and almost all are
community-associated and methicillin-resistant organisms.(61)
‘
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Preoperative factors:
Preoperative shower with skin antiseptics even though widely practiced, has no clear
evidence that alters the incidence of SSI. (22)
Skin antiseptic during operation:
Several skin antiseptic agents have been used to decrease the skin bacterial contamination,
before skin cut is made. Many studies have been conducted to asses the efficacy of various
topical antiseptic solutions to stop wound infections in clean contaminated wounds.
A multicentric trial comparing Chlorhexidine and povidone-iodine for decontamination of
operation site in clean-contaminated operations, has proved a statistically significantly lesser
incidence of wound infection in the chlorhexidine arm than in the povidone-iodine arm.(62)
In colonic and rectal operations, patients on whom chlorhexidine was used had a higher
wound infection rate compared with the incidence in the patients on whom povidone-iodine
was used.
Another single institution trial examined three different skin antiseptics and each solution was
used.(22) each antiseptic solution ws used sequentially, each solution for 6 months.  The
difference in the rate of infection was significant between the povidone-iodine arm & iodine
povacrylex in isopropyl alcohol arm, when the difference between 2% chlorhexidine arm and
70% isopropyl alcohol arm was compared.(63)
There are other recent studies which have proven the superiority of the Chlorhexidine
solution over Povidone Iodine solution and so chlorhexidine-alcohol must be used wherever
possible.
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Wound protectors:
Theoretically, wound protector device will decrease the contamination of the surgical site
with and decrease mechanical trauma by protecting it from contaminants. Therefore, use of
surgical site protectors as a preventive measure of wound infection have been studief by
several authors. Raahave and his colleagues have seen a considerable decrease in density of
bacteria in the surgical site, when a surgical site edge protector device was applied.(64)
However, there was no statistically significant decrease in the incidence of surgical site
infection when the device was used and so there is no relation with decreasing SSIs when
wound protectors are used.(65)(66)(67)
In about 4 RCTs on patients undergoing colorectal operation, there was no correlation found
in the rate of wound infection and the use of wound protector device  when a patients
undergoes an abdominal operation.(68)(67)
Another retrospective study assessed the utility of wound protection device in laparoscopic
operations to externalize the specimen and for anastomosis. There was no statistically
significant difference between the group in which wound protector device was used and the
group where it was not used.(69)
An RCT done on patients undergoing trans-abdominal operations showed a significant
decrease (29 to 14 percent) in the incidence of wound infection when impervious surgical site
protector device was used.(70) There was drastic reduction in the infection rate when the
wound was found contaminated pre operatively.
A non-randomized study compared the rate of surgical site infection in patients undergoing
GI operations when wound protector instrument was used and when it was not used. There
was reduction in the surgical site infection from 15 to 2.4%.(66)
There has been few other RCTS which studied different types of protection devices, in
various surgical procedures and the results have been unequivocal. This implies that the role
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of surgical site protectors in reducing the surgical site infection rate, in various abdominal
operations, is not clear ,(22) and more RCTs are necessary to clarify this question.
Mechanical bowel preparation:
Mechanical bowel preparation (MBP) is commonly done to decrease fecal contamination
intra operatively before elective colorectal operations. Studies have aimed at comparing the
rate of septic complications like surgical site infection, fascial dehiscence and anastomotic
leakage with mechanical preparation. In a multicentric randomized trial done in Netherlands,
patients who underwent mechanical bowel preparation and who did not were compared with
anastomotic leakage as the primary outcome. The incidence of anastomotic leakage did not
differ between the two groups. Patients who had MBP developed fewer abscesses after
anastomotic leak compared to those who did not. Fascial dehiscence and other septic
complications along with mortality rates were same in both the groups.
A review article by Slim et al,(39) included 7 studies (Total number – 1454 patients,
mechanical bowel preparation(MBP) was given to 720, and others did not have  bowel
preparation) and they were followed up  for 7-60 days. There was higher rate of anastomotic
leakage in patients who had bowel preparation. In addition there was no  statistically
significant difference in the rate of surgical site infection and rates of other complications
between the group who had MBP and who did not have MBP.(39)
In the background of these studies, which have concluded that bowel preparation did not have
additional benefits in reduction of post operative complications but can result in more
anastomotic leakage, colorectal surgeons from Canadian society have recommended pre
operative MBP to be avoided.
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Use of laparoscopy:
The report that there has been reduction in the post operative infectious complications of the
wound, by the use of laparoscopy, has been confirmed by few meta-analyses.
The incidence of surgical site infection was studied in a meta analysis containing 25
randomized trials and 1771 subjects. The trial compared the rate of surgical cite infection in
operation group with laparoscopic group and found a statistically significant reduction in the
laparoscopic group. But, the study did not show any difference in the rate of development of
intra abdominal collection post operatively(71)
Another meta-analysis which included many larger randomized studies which were partly
completed when first analysis was conducted, Colon Carcinoma Laparoscopic or Open
Resection or COLOR and Conventional versus laparoscopic assisted surgery in colorectal
cancer [CLASICC] studies, was published after 12 months. There was significant reduction
in the complications of the surgical site in the laparoscopic operation arm when compared
with the patients who underwent open operation.(72)
In five of the largest multicentric trials, where patients undergoing laparoscopic surgery was
compared with patients undergoing open surgery, each study report separately demonstrate
that there was no statistically significant difference in the rate of surgical site complications
and the morbidity between both the study arms.
Limitation of these trials is that patients undergoing laparoscopy converted open operation
was considered in laparoscopic procedure arm as intention to treat. There is a chance of data
getting skewed since patients with large open incision was included in laparoscopic arm.
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Another limitation of these studies is that patients with colon cancer, alone was included.
Patients with inflammatory bowel disease and diverticular disease were not included (22)
These large RCTs, though as individual studies, have not demonstrated any difference in
surgical site infection, as meta-analysis which includes many smaller trials, they have shown
significant reduction in the rate of surgical site infection. Hence, it is possible that the risk of
of surgical site infection in patients undergoing laparoscopic operation, is not more than in
patients undergoing open operation and can well be less. So, while measures to decrease
wound infection are considered, laparoscopic colorectal resection must be tried whenever
possible.(72)
Prophylactic placement of intra abdominal drain:
It was believed that prophylactic placement of intra abdominal drain might decrease the
incidence of surgical site infection by allowing the drainage of accumulated blood and fluid
and allowing early detection of anastomotic leakage.(22) However, it has been argued that
prophylactic placement of intra abdominal drain can actually increase the incidence of
complications by causing anastomotic site infection because it allows communication with
skin flora. Various studies have been performed examining this aspect. Evidence shows
prophylactic placement of intra abdominal drain can be detrimental and use of intra
abdominal drain should be avoided.
Suturing of fascia:
Different techniques and different suture materials to close the fascia have been studied. A
metaanalysis  that assessed different fascial closure techniques with  different suture materials
did not show any significant difference in the  incidence of wound infections.(39) Another
clinical  trial compared fascial closure with slowly absorbable suture  material continuously
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with facial closure with rapidly absorbable suture in an interrupted manner, did nto show any
statistically significant difference in the rate of SSIs .(73)
While closing the fascia continuously an ideal suture length to wound length ratio should be
> 4 so as to decrease the rate of incisional hernia.(74) as evidenced in a recent RCT
Also, an RCT comparing rapidly absorbable suture covered with antiobiotis with slowly
absorbable suture showed significant decrease in the incidence of SSI.(75)
A study comparing continuous versus interrupted closure of fascial layer, did not show any
variation in the incidence of SSI.
NS wound irrigation helps in improving the outcome of surgical wounds
In tissue healing the microbes, dead tissue and foreign body are scavenged because of
increased vascular permeability during the phase of inflammation of the  tissue in response to
tissue injury e.g. complement cascade activation, cytokine release, cytotoxicity, etc.(76) but
when there is immunodeficiency bodies defence mechanism to overcome microorganisms
fails which  can result in poor neovascularisation and granulation of tissue and infection
ensues.
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Bacterial contamination is of fundamental importance in the development of wound infection.
Bacteria associated with SSI reflect the area that provided the inoculum for the infection to
develop. S. aureus and related species Staphylococcus remain the commonest bacteria
colonized from wounds. However, at locations where high volumes of gastrointestinal (GI)
operations are performed, the predominant bacteria will include Enterobacter species and
Escherichia coli. In most studies, group D Enterococcus continues to be a common pathogen
isolated from surgical site infections.(77) . There is significant decrease in the number of
bacteria present during closure of skin when normal saline is  used to irrigate the surgical site
in animal models.(76)
Hence, it is considered that intra operative normal saline wound irrigation helps in decreasing
the bacterial contamination of the wound from the intestines and thus decreasing the rate of
wound infections.
Use of various irrigating solutions
Sindelar and Mason3,4 studied the effects of Povidone Iodine solution on wound infection
through an randomised controlled trial.  Patient aged between 9 and 80 years and
undergoing abdominal, GI and GU operations were enrolled. Patients were randomly
allocated into povidone iodine irrigation group (1% available iodine) with normal saline
irrigation group. Wound was irrigated with given solution in both the groups, in 60 seconds
during operation. Wound were categorised based on their degree of contamination. The rate
of wound infection was less in the povidone iodine group compared to normal saline group.
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The  treatment group did not have untoward effects on wound healing.
Singh and colleagues7 examined 90 patients in a prospective comparative study. In this
study the subjects who had clean contaminated procedures were grouped into three study
arms. Wound irrigation was given with 5 percent povidone iodine, solution of metronidazole
incombination with povidone iodine and normal saline. The incidence of SSI was 10 percent
each in the first two groups and thirty percent in the third group.
Sindelar and Mason did another clinical tial in which patients undergoing abdominal
operations were included. Peritoneal cavity was irrigated with one liter of povidon iodine for
60 seconds prior  to abdominal closure in one group. Normal saline  was used to irrigated
the peritoneal  cavity of another group. The incidence of intraabdominal collection was  less
in the  povidone iodine irrigation group compared to the normal saline group One group.
There was increase in iodine level in the  serum in few patients one day later. However there
was no change in the  level of  thyroxine nor any adverse effects of elevated levels of iodine.
In another clinical trial, de Jong et al compared the efficacy of wound irrigation with
povidone Iodine with no wound irrigation in patients who had abdominal surgeries. The trial
was conducted in two phases: 1% povidone Iodine in phase 1 and 10% povidone Iodine in
the second phase. There was no statistically significant difference in the treatment arm and
the control arm. There was no risk identified.
In another RCT at Limerick Regional Hospital, Tighe and colleagues included 131 patients
undergoing appendectomies. The patients were distributed among three arms. The patients
received povidone Iodine irrigation intraperitoneally and also on the wound in the 1st arm. In
the second arm, the patients were irrigated with sterile water and the third arm got no wound
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irrigation.There were no significant differences between the 3 groups. There were no
identified complications.
Rogers and colleagues conducted a clinical trial at Nashville Veterans Administration
Hospital on patients having general surgery operations. The surgical wound was classified
based on the level of contamination. On seeing the subjects for a period about 4 weeks, it
was found that the rate of SSI was nuch lesser with the treatment arm. No risk was
identified.
Johnson et al performed a clinical trial to study the effect of perineal wound irrigation with
povidone Iodine post operatively, on patients who underwent APE for rectal cancer. The
treatment group received wound irrigation with povidone Iodine and the control arm
received NS wound irrigation.There was statistically significant decrease in SSI rates in the
study arm compared with the control arm. Also the wound healing of the abdominal wall
was better in the treatment arm even though some of them developed abdominal wall sinus
which was not statistically significant.
A randomised trial conducted by Parker et al on patients who underwent major colonic
operation for cancer. The treatment arm was given wash with povidone Iodine solution and
the control arm received wash with sterile water. The rate of SSI in treatment arm was very
less compared to the control arm with statistical significance.
An RCT by Sindelar and colleagues on subjects who at presentation had contaminated
abdomen. Intraperitoneal irrigation was given in both the treatment group and the control
group; the treatment arm with povidone Iodine solution suctioned 1 minute after irrigation
and the control arm with normal saline. There was more incidence of intra abdominal
complications in control arm than in treatment arm which was statistically significant. There
was abnormal wound healing in both the groups which were not statistically significant. The
Iodine levels in the blood were elevated in the povidone Iodine wash group 1 day after
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operation which became normal in 1 week. However, there was no systemic toxicity due to
increased Iodine levels.
Efficacy of povidone-Iodine irrigation in cardiovascular surgery
Angelini et al performed a comparative research on patients who underwent repeat sterna
operation for secondary haemorrhage in the early post operative period. The treatment arm
received irrigation with povidone Iodine and the control arm had no wash. There was
statistically significant difference in the rate of sternal operation site infection between the
groups, with rate of SSI being less in the treatment group.
A randomised trial conducted by Ko along with his colleagues on patients who underwent
sternotomy for cardio pulmonary operation.performed a single-blinded RCT on 1980 adult
patients who underwent cardiopulmonary bypass surgery with a sternotomy. The treatment
arm received irrigation with povidone Iodine and the control arm had normal sasline wash.
There was  no statistically significant difference in the rate of sternal operation site infection
between the groups, even though the rate of SSI was less in the control group.
Efficacy of povidone-iodine irrigation in orthopaedic surgery
There were 2 Randomised controlled trials on patients receiving wash with povidone-Iodine
in orthopaedic surgery. Cheng et al studied the effect of povidone Iodine wound irrigation
on SSIs in spinal operations. The treatment arm received irrigation with povidone Iodine
and the control arm had nomal saline wash. There was statistically significant difference in
the rate of deep surgical site infection between the groups, with rate of SSI being less in the
treatment group. The difference in the incidence of superficial SSI was not statistically
significant.
There was another randomised trial by Chang at al assessing the effect of povidone Iodine
wound irrigation on SSIs in spinal operations. The treatment arm received irrigation with
povidone Iodine and the control arm had normal saline wash. There was statistically
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significant difference in the rate of deep surgical site infection between the groups, with rate
of SSI being less in the treatment group. The difference in the incidence of wound
dehiscence was not statistically significant. Also there was no statistically significant
difference between the two groups in the rate of other post operative complications like
increased pain, spinal fusion, wound healing etc.
Efficacy of povidone-iodine irrigation in urologic surgery
Richter and colleagues investigated in a prospective comparative study the effect of
povidone-Iodine wound wash in urology patients who underwent open prostate operations.
The patients in treatment arm were recruited in the first 6 months of the study and they
received wash with povidone Iodine and patients in control arm were recruited in the next 6
months of the study and they received normal saline wash. There was statistically significant
difference in the rate of deep surgical site infection between the groups, with rate of SSI
being less in the treatment group. None of them had identifiable risks.
Risks of povidone-iodine irrigation
The adverse effects of povidone Iodine surgical site and peritoneal wash was studied by
Strife et al on a 15 years old female who underwent abdominal operation for severe PID.
She was given peritoneal wash with copious amount of povidone Iodine. There was
elevation of SGOT associated with protein loss in urine and microscopic presence of blood
in urine after one day of operation. There was also elevation of levels of Iodine in urine and
serum upto 3 days post operatively. However,toxicity due to Povidone-Iodine was not
demonstrated in this patient.
There is case series which proves that povidone-Iodine may cause thyroid function to get
suppressed transiently in premature babies who underwent intestinal anastomosis and the
author opined that their thyroxine levels be tested after 2 weeks post operatively.
The major dangers associated with washing the wound or the peritoneal cavity with
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povidone-Iodine were related functioning of thyroid in all these studies. Different events
have been recorded, however there was no life threatening adverse effect reported.
Occasionally, unsterile povidone-Iodine solution can result in development of infectious
complications and so utmost care must be ensured that it is sterile before use. When topical
povidone-Iodine is used in burns patient, it can result in severe metabolic acidosis owing to
the absorption of Iodine. Thus, when the ointment is used on patients with large burns
wound and in patients with renal dysfunction, extreme care and precautions must be taken.
Povidone-Iodine wash is best avoided, in general, in patients with thyroid disease, renal
disease, Iodine sensitivity or burns until more evidence is available..
Based on these studies, it can be concluded that povidone-iodine surgical site or peritoneal
irrigation may be useful in reducing the rate of SSIs. The safety profile is still not entirely
clear and more studies are necessary to determine if povidone-iodine is the “ideal” solution
for irrigation.
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The various methods and solutions used for cleaning the wound
For many years and centuries surgical wounds are being cleaned and washed with various
techniques and solutions, so as to hasten wound healing. After the advent of antiseptic since
Lister’s time, they are being used as irrigation agents. Owing to their toxicity and poor
effects on wound healing, normal saline has been used as an alternative recently. Wound
irrigation rather than swabbing is suggested since swabbing of the wound can damage the
epithelialising tissue.
The practice of wound cleansing
Low-pressure irrigation of the wound, usually normal saline in a syringe, is the
recommended method of cleaning in the recent times and studies to prove the practice
should be assessed.
All the surgical wounds do not need cleaning.  Miller and Dyson found cleansing the wound
to be not useful since it can hinder wound healing. Wounds which are healing by secondary
intention needs cleansing only to excise the debris and superficical slough, excess exudates
to be removed and it is not useful in removing bacteria.
Flanagan stated that the benefits of washing the wound were to:
-Assessing the wound
-Hydrate the wound so as to give an environment which is moist
- Minimize injury to the tissues while removing dressing materials
However, rehydration can be achieved using dressings which can retain the moisture and
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many interacting agents are used in the modern dressings (Ballard & Baxter, 2000) so as to
provide ideal surrounding for cell growth. Interactive agents aim to alter the wound bed in
order to promote a suitable environment for cell migration and growth (Ballard and Baxter,
2000).
The evidence for irrigation
According to Towler (2001),wound management has been based upon the expert opinion
rather than evidence-based since good RCTs are less in number. So, other means of
evidence like case reports, retrospective or prospective observational or case-control studies
have to be relied upon for managing the wounds. Level 1 evidence is required to
authoritatively implement the methods of wound cleansing.
The principle of wound cleansing is that flushing the wound help in removing the debris and
excessive fluids in the surface of wounds. Irrigating the wounds means to flush the wound
with the given solution. The important components of wound irrigation are the volume of
the solution and the pressure in which it is administered on to the wound so as to make
optimum healing environment. The optimum pressure in which the wound debris can be
removed has been suggested by Fletcher at al, to be 4-5 psi. A higher pressure will cause
damage to the wound and can result in bacterial translocation and so harmful effects. On the
other hand, a lower pressure will not have any effect other than wetting the wound.
The most common instruments used for irrigation are syringes and needles which are very
much available in the surgical wards. Other equipments which have been suggested for
wound wash are shower head, spraying canisters and ampoules which are semi rigid. These
instruments reduce the incidence of needle stick injuries also.
Irrigation of wounds must happen in a sterile environment and approximately 250-500 ml of
the given solution is recommended for effective wound cleansing.
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Choice of cleansing solution
Options of solutions used for irrigation can be ranging from antiseptics to tap water. Some
of the antiseptics are potential carcinogens are hence are best avoided (Mallet and
Dougherty, 2000).
According to Flanagan (1997)an ideal solution for cleansing the wound require the
following features
- Non-toxic to human wound tissues
- Remains effective when  organic material is present
- can reduce the burden of mcrobes
- should not yield to allergic or hypersensitivity
- Can be bought easily and less expensive
- should not be a unstable solution with short half life.
According to Lawrence, the antibacterial effects of irrigation of wound is mainly due to the
physical action on the tissue and not the antibacterial effect of a given solution.
Inspite of the presence of supporting evidence for normal saline as an ideal irrigant solution,
conclusive research is not available and so an ideal irrigation solution is still not clear.
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Normal saline wound irrigation done in other operations
A randomised study was conducted by Güngördük K, et al in Mardin Women and Children
Hospital, Mardin, Turkey, to find out if normal saline irrigation reduce the wound infection
in caesarean delivery or not. The study was conducted on patients who underwent elective
and emergency LSCS. The treatment arm received irrigation with normal saline and the
control arm had no wash. There was statistically significant difference in the rate of deep
surgical site infection between the groups, with rate of SSI being less in the treatment group.
There was no difference in the incidence of SSI even after normal saline wash in subjects
undergoing LSCS.
Another prospective randomized study was undertaken by Oestreicher M, et al among 540
patients submitted to a general surgical operation. The operative site and the wall before
skin closure have been washed either with saline or with Betadine-R solution.
Bacteriological samples were taken before irrigation. The contamination rate reached 60%
in visceral surgery, 30% in bone surgery. Postoperative wound sepsis nearly reached 6%.
There was no difference between the NaCl and Betadine groups.
Hartwich JE, et al. conducted a study to study if saline wound irrigation helps in reducing
SSI in paediatric population undergoing appendectomy. Outcome was better(78) with
normal saline wound irrigation in appendicitis(79)
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Animal study
In guinea pig models, a study was conducted to assess the effect of normal saline
prophylactic wash in reducing the SSI.  There was significant reduction in the bacterial load
at the time of closure of skin and thus the incidence of surgical site infection.
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METHODS
Study design
The study was a randomised controlled, double-blinded trial to compare the rate of incisional
surgical site infection in wounds which were washed with either normal saline or not washed.
The trial was approved by Institutional review board, of our institution. Patients were
enrolled after obtaining informed consent. The trial has been registered with CTRI (003197).
Study setting
The study was conducted in the department of general surgery, unit-2 at our institution.
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Intervention and Comparator agent:
Normal saline wound irrigation group and
No wound irrigation group respectively.
Inclusion Criteria:
All open abdominal elective colorectal surgeries
Laparoscopic surgeries with more than 7 cm long incision
Exclusion Criteria:
1. Abdominal wound is contaminated or dirty at
presentation (pre operatively) e.g. Trauma,
Intra-abdominal sepsis.
2. Layer of skin is not closed.
3. Higher antibiotics are required pre operatively.
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Method of randomization:
Computer generated block randomization with block sizes of 2, 4, and 6 at 25%, 25% and
50% respectively.
Method of allocation concealment:
Randomized and sequentially numbered opaque envelopes were opened in the operation
theatre just before the skin closure.
Blinding and masking:
Both the investigator and the patient were blinded.
Primary Outcome:
Rate of abdominal incisional surgical site infections (using CDC criteria for incisional
surgical site infection)
Secondary Outcomes:
Other risk factors associated (Diabetes mellitus, hypertension, immunosuppression, obesity,
anemia, hypoalbuminemia, neoadjuvant chemoradiation, presence of stoma, duration of
operation, material used to close skin etc.).
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Target sample size and rationale: 226.
Using a retrospective analysis, a sample size of 226 patients (113 in each arm - normal saline
irrigation group and no irrigation group) will be sufficient to detect a difference of 15%
between the groups in wound infection rate with 80% power and 5% significant levels. 15%
difference represents the difference between 10% wound infection rate in normal saline
irrigation group and 25% wound infection rate in no irrigation group.
Proportion in No irrigation group - 0.25
Proportion in Normal saline irrigation group - 0.15
Risk difference - 0.1
Alpha error% - 5
Power % - 80
Number of comparison groups - 2
Required sample size for each arm - 113
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Sample size (n) is calculated by the following formula:
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Phase of trial:
Phase III clinical trial
Duration of trial:
December 2012 to August 2014
Statistical Analyses:
Data was entered in a epidata.
Comparison of the two groups on surgical site infection rate was done using chi-square test.
Chi-square test for other risk factors was used to identify the independent variable.
Independent sample T test was used for analyzing constants.
Interventions:
Patients after informed consent were accompanied by a sealed envelope which was allotted to
the patients serially. Thus, the patients were randomly allocated to either the treatment group
i.e. the normal saline wash group or the control group i.e. No wash group.
The sealed opaque envelopes were opened in the operation theatre after rectus muscle layer
was closed and the procedure executed accordingly.
According to the group the patient was allocated to, the procedure was executed.
In the normal saline wash group, freshly opened 500ml normal saline bag was opened and
used to irrigate the wound just before closure.
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Allocated to intervention NS wash (n=70)
Received allocated intervention (n= 70)
Did not receive allocated intervention
(give reasons) (n= 0)
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RESULTS AND ANALYSIS
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Fig. 1 showing the Age distribution of patients in both treatment and control arms
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The mean age among the two arms was comparable.
N Mean Std. Deviation Std. Error
NS
wash
65 46.9 14.08 1.75
No wash 63 47.6 13.38 1.68
Table 1 shows the mean ages in the two arms along with the standard
deviation
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SEX DISTRIBUTION:
NS wash No wash
Male 38 37
Female 27 26
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Fig. 2 showing the sex distribution of patients in both treatment and control arms
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Chart Title
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Distribution of parameters assessed
Parameter Study arm(NS wash) Control arm(No wash)
DM 12 18
Hypertension 15 12
Obesity 17 14
Anaemia 18 26
Hypoalbuminemia 8 5
Immunosuppression 6 3
Preoperative Chemoradiation 33 22
Presence of stoma 53 50
Operated by consultants 49 45
Chlorhexidine skin preparation 60 59
Transverse skin incision 9 13
Duration of surgery >3 hrs 45 33
All the parameters assessed were equally distributed between the two arms.
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NS wash No wash
Infection present 36 29
Infection absent 29 34
Pearson chi2 =   1.1197   Pr = 0.290
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Fig. 3 showing the presence of infection among patients in both treatment and
control arms
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Infection
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Fig. 4 showing relation of gender and the incidence of incisional wound infection
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Infection DM
Present Absent
Present 14 51
Absent 16 47
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Fig. 5 showing relation between presence of DM and the incidence of incisional
wound infection
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Fig. 6 showing relation between presence of hypertension and the incidence of
incisional wound infection
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Infection Anaemia (Hb<10g %)
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Fig. 7 showing relation between presence of anaemia and the incidence of
incisional wound infection
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Infection Hypoalbuminemia (Alb<3g%)
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Fig. 8 showing relation between presence of hypoalbuminemia and the incidence of
incisional wound infection
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Infection BMI
Underweight Normal obese
Present 12 37 15
Absent 15 32 16
Pearson chi2=   0.7201   P = 0.698
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Fig. 9 showing relation between patients with varying BMI and the corresponding
incidence of incisional wound infection
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Infection On immunosuppression
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Fig. 10 showing relation between presence of immunosuppression and the
incidence of incisional wound infection
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Infection Intra operative contamination
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Fig. 11 showing relation between presence of Intra operative contamination
and the incidence of incisional wound infection
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Infection Wound protection device
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Fig.12 showing relation between usage of wound protection device and the
incidence of incisional wound infection
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Infection Carcinoma
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Fig. 13 showing relation between carcinoma and the incidence of incisional wound
infection
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Fig. 14 showing relation between various suture material used and the incidence of
incisional wound infection
Ethilon
2 1
Present
Absent
89
Infection Duration of surgery
<3hrs >3hrs
Present
23 37
Absent
18 41
Pearson chi2 =   0.8065   P = 0.369
0
5
10
15
20
25
30
35
40
45
<3hrs
Duration of surgery
23
18
Fig. 15 showing relation between duration of surgery and the incidence of
incisional wound infection
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Fig. 16 showing relation between experience of the operating surgeon and the
incidence of incisional wound infection
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Fig. 17 showing relation between presence of pre operative stoma and the incidence
of incisional wound infection
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Fig. 18 showing relation between preoperative chemoradiation therapy and the
incidence of incisional wound infection
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Fig. 19 showing relation between new stoma created and the incidence of incisional
wound infection
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Fig. 20 showing relation between incision and the incidence of incisional wound
infection
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Fig. 21 showing relation between skin preparation and the incidence of incisional
wound infection
Povidone Iodine
Skin preparation
5 4
Present
Absent
96
RESULTS
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A total of 138 patients were included in this trial, out of which 10 patients were lost to follow
up at the last visit. Among the rest of the patients, 65 were randomised to the treatment arm
i.e. Normal saline wash group, and 63 were included in the No wash group.
A total of 128 patients were included in the statistical analysis.
Out of the total of 128 patients, 84 were males which are consistent with the international
statistical figures. The male: female ratio was found to be 1.9:1.
Colorectal diseases were more prevalent among the age group 30-50 and there was equal
distribution of patients among both the intervention arms in all the age groups.
Almost 88% of the patients had a diagnosis of malignancy and others had benign colorectal
diseases like inflammatory bowel disease, tuberculosis etc.
Most of the patients were geographically from Bangladesh and West Bengal followed by
TamilNadu and Andhra Pradesh.
The incidence of incisional SSI was found to be 55.38% in the treatment arm and 44.62% in
the control arm. The overall incidence of incisional surgical site infection in colorectal
operation during the period December 2012 to August 2014 was 50.78%
Fig. 5 shows relation between presence of DM and the incidence of incisional wound
infection. Diabetes mellitus was present in 23.44 % of the study population and 14/30 patients
had developed incisional SSI.
Fig. 6 shows relation between presence of hypertension and the incidence of incisional wound
infection. 21.09% of the study population had systemic hypertension and 14/27 developed
infection post operatively.
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Also found were associated risk factors like anaemia, hypoalbuminemia, obesity, presence of
immunosuppression, presence of stoma pre operatively or post operatively, chemo radiation
therapy etc.
Intra operative factors like the experience of the surgeon, skin preparation solution used,
wound protector devices, duration of surgery, creation of a new stoma, suture material used to
suture the skin and presence of intra-operative faecal contamination were also considered to
find out whether they affect the incidence of incisional surgical site infection.
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DISCUSSION
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There is high morbidity and mortality related to incisional surgical site infections following
colorectal surgery. Colorectal resections themselves are associated with higher morbidity and
morbidity and mortality compared to other abdominal operations.
As we have noticed in this study, the large group of patients undergoing colorectal operations
have malignancy as their primary diagnosis.
There is male predominance with a male to female ration of 1.9:1, and more males have been
included in our study. The age distribution of the colorectal diseases follows a normal
distribution.  There was more prevalence of colorectal diseases among the age group 30-50
years and there was equal distribution of patients in both the intervention arms in all the age
groups.
Out of the total of 128 patients, 65.6 %( n= 84) were males which is consistent with
observations from other centres around the world.
Almost 88 %( n=113) of the patients had a diagnosis of malignancy and others had benign
colorectal diseases like inflammatory bowel disease, tuberculosis etc.
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The overall incidence of incisional SSI in open colorectal operations during the period
December 2012 to August 2014, at the department of general surgery2, Christian Medical
College Vellore, was 50.78%.
The incidence of incisional surgical site infection following open colorectal surgery has been
reported to range from 5% to 26% [4–8].
The incidence of SSI for colon surgery was 15.0% (6,691 of 44,751) and rectal surgery was
17.8% (3,230 of 18,187) in a retrospective nationwide Japanese surveillance-based study.
Most of the variation in the incidence of incisional SSI is probably due to modification of
CDC definitions of SSI and inter-observer variation among differing personnel carrying out
the assessments for infection. In this study strict CDC definitions were adopted.
Some of these studies include also the laparoscopic surgeries rather than just open colorectal
operations which has a much lesser incidence of surgical site infections
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The degree of contamination of the surgical wound with bacteria is fundamental to the risk of
onset of SSI. We hypothesized that in a colorectal operation, because of the heavy bacterial
load of colon and rectum, the procedures of anastomosis were associated with faecal
contamination at the surgical site and so there was increased chance of developing wound
infection, if the patient has undergone end-to-end anastomosis for various types of colectomy
and for rectal anterior resection in comparison with no anastomosis in abdomino-perineal
resection and in Hartmann’s operation.
However, Konishi and colleagues have reported that the rate of SSI was lesser in colonic
operations compared to rectal operations . This is because operation for rectal malignancy
involves creation of stoma, long course neoadjuvant chemoradiation therapy along with total
mesorectal excision and anastomosis close to anal verge. These factors possibly lead
prolonged operation and can cause higher bacterial contamination. Bacterial contamination
was the basis of improving the incidence of incisional surgical site infection by normal saline
wound irrigation.
The incidence of incisional SSI was found to be 55.38% in the treatment arm and 44.62% in
the control arm.  This result is in contrast to the expectation that Normal saline wound
irrigation will help in reducing the surgical site infection. However, due to lack of adequate
numbers, it is not possible to draw any definite conclusion from the above observation and
there is need for larger sample size to show adequate statistical difference between the two
arms, the normal saline wash arm and the no wash arm.
.
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Other risk factors which were assessed were
Demographic factors:
Age and sex
Pre operative factors:
Primary diagnosis as malignancy
BMI
Diabetes mellitus
Systemic hypertension,
Anaemia
Hypoalbuminemia
Immmunosuppression
Presence of stoma pre operatively
Neoadjuvant chemoradiation therapy
Intra operative factors studied were:
Experience of the operating surgeon
Skin preparation used
Duration of surgery
Intra operative contamination
Wound protectors
Suture material used for skin
Stoma creation at the end of the operation
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Even though there were differences in the number of patients who developed incisional SSI
between the groups, this difference was not statistically significant, with p value more than
0.05 in all these parameters. There is a necessity of a larger sample size to determine a
statistically significant difference and thus draw conclusions regarding their association with
the incidence of SSI.
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CONCLUSIONS
106
1. There was no significant difference observed in the rate of SSI between patients whose
wounds were irrigated with normal saline and those whose wounds which were not. However,
the sample size was not reached and therefore no conclusion can be derived. It is planned to
continue the study till the sample size is reached.
2. The incidence of incisional SSI in patients who underwent elective open colorectal
operations in our institution was higher compared to the incidence reported in other studies in
the world. This could be due to lack of uniformity in the  and to diagnose SSI.
.
3. Other factors which might play a role in the development of surgical site infection were
also studied. However, none of them showed definite association.
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LIMITATIONS:
1. It was a time bound clinical trial conducted in a single centre and so there is paucity of data.
2. There was no prescribed pressure at which the irrigation was to be performed. This could
be an important factor.
3. The interim analysis of a clinical trial might not depict the entire picture of the intervention.
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POTENTIAL FOR FURTHER RESEARCH
It is an ongoing challenge to prevent wound infection in elective colorectal operations. There
is a trend towards laparoscopic colorectal operations from open procedures which will imply
shorter hospital stay, smaller incisions and development of surgical site infection will be less
severe, less frequent and less intense in the superficial and deep compartments of the
abdominal wall. Organ or space surgical site infection will continue to be a potential source
of mortality and morbidity. SSI needs to be standardized as for surveillance methods and
definitions are concerned, which will help clinicians to assess the wounds objectively.
Thus, it requires a continuous and prolonged use of all the techniques and methods which are
accepted to reduce the wound contamination intra operatively and a close monitoring of the
preventive measures for conditions of the surgical site that promote wound infection.
Newer techniques have to be discovered to decrease surgical site infection in colorectal
operations. It seems unlikely that further advances in the field of microbiology (in the form of
systemic antibiotics) will improve the results. The methods could be aiming at a
physiological optimal condition in the patient by maintaining homeostasis, normothermia,
intra-operative supplemental oxygen and good glycemic control. It seems appropriate to use
wound protection device while extracting specimen to avoid contact of the specimen with the
surgical site.
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ANNEXURES
PROFORMA
(A randomised controlled trial comparing the post operative abdominal surgical site wound
infection in patients who are given an intra operative normal saline irrigation with the
patients who are not given any irrigation)
Serial no.:
Name : Age :              Sex:           Hospital No.:
Address :                                             Contact No:
PRE OPERATIVE:
Primary Diagnosis:
Weight(in Kg):                Height(in cm):                      Body mass index(wt/ht2):
Co-morbidities :
1. Diabetes mellitus - Yes/No
2. Hypertension - Yes/No
3. Haemoglobin <8 g% - Yes/No
4. Albumin <3 g/dL - Yes/No
5. On immunosuppressants - Yes/No
6. Chemo radiation - Yes/No
7. Stoma present - Yes/No
Operation performed :
Elective / Emergency :
INTRA-OPERATIVE PERIOD:
Surgeon : Consultant / PG trainee
Pre-operative antibiotic used :
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Skin preparation :  Chlorhexidine / Povidone Iodine
Incision made :  Transverse / Vertical
Length of incision ( in cm ) :
Any intra operative contamination :  Yes/No
Wound protection device used : Yes/No
Duration of surgery (in hrs and min) :
Skin closed : Yes/No
Suture material used for skin closure :
Stoma trephined: Yes/No
POST OPERATIVE PERIOD
Antibiotics used :  Yes/No
If yes, what antibiotics
Post operative complications : Yes/No
If yes, the event (Anastomotic leak /LRI /UTI /Others) :
(6) Wound assessment Till
discharge
1st OP
visit
14-16
days
1st month
Symptoms :
Pain :  Yes/No
Swelling : Yes/No
Discharge :  Yes/No
If yes, serosanguineous/pus/others:
Fever : Yes/No
Signs :
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Tenderness : Yes/No
Erythema : Yes/No
Increased warmth : Yes/No
Wound dehiscence : present / absent
Sutures or staples removed: Yes/No
Investigations :
Pus culture and sensitivity : done / not done
If done, Is it significant? Yes/No
Radiological investigation for deep incisional abscess?
If reoperation, findings(evidence of infection /
abscess):
Diagnosis of surgical site infection made by the
surgeon : Yes/No
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Information sheet
INFORMED CONSENT
Christian Medical College, Vellore
Department of General Surgery
A randomized controlled trial comparing the rate of surgical site infection when normal
saline wound irrigation is given and when not given in colorectal resections.
Information sheet
You are being requested to participate in this study to find out if normal saline wound
irrigation when given intra operatively, decreases the surgical site infection rate by
decreasing the bacterial contamination from the bowel and the skin. We hope to include
about 226 people from this hospital in this study.
Does Normal saline irrigation help in preventing surgical site infection?
Any operation carries the risk of wound infection. There are some known factors which
affect wound healing and some are not known. It is not known whether normal saline
wound irrigation decreases the risk of wound infection or not.
Does Normal saline wound irrigation have any side effects?
Normal saline wound irrigation does not have any proven adverse effect on the wound or
the body.
If you take part what will you have to do?
If you agree to participate in this study, you will be either given normal saline wound
irrigation or no irrigation at all. Neither you nor your doctor will have any choice in whether
you will get normal saline wound irrigation or not as this will be decided by a computer
program; this is like tossing a coin and you have an equal chance of getting either treatment.
Also, neither you nor your doctor will know which group you belong to till the study is over.
All other treatments that you are already on will be continued and your regular treatment
will not be changed during this study. You will be expected to come for a review to the
hospital 2 weeks after the operation and again 2 more weeks later. You will be asked
questions about your wound, and you will be examined at each visit. You will be asked to do
a microbiological test to look for organisms in the wound if wound infection is suspected by
your doctor. No additional procedures or blood tests will be conducted routinely for this
study.
If at any time you experience any problems, you will be expected to report this to the
doctor. You will also be contacted by telephone as and when needed in between your visits
by the doctors in this study who will ask you about any symptoms of wound infection you
are experiencing.
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Can you withdraw from this study after it starts?
Your participation in this study is entirely voluntary and you are also free to decide to
withdraw permission to participate in this study. If you do so, this will not affect your usual
treatment at this hospital in any way.
What will happen if you develop any study related injury?
We do not expect any injury to happen to you but if you do develop any side effects or
problems due to the study, these will be treated at no cost to you. We are unable to provide
any monetary compensation, however.
Will you have to pay for normal saline wound irrigation or the culture?
You will not have to pay extra for Normal saline wound irrigation. Any other treatment or
investigation that you usually take will continue but the usual arrangements that you have
with the hospital will decide how much you pay for this.
What happens after the study is over?
You may or may not benefit from type of treatment you are given. Once the study is over, if
the normal saline wound irrigation has helped, we might continue to do the same for our
patients on a regular basis. You will not be involved in this.
Will your personal details be kept confidential?
The results of this study will be published in a medical journal but you will not be identified
by name in any publication or presentation of results. However, your medical notes may be
reviewed by people associated with the study, without your additional permission, should
you decide to participate in this study.
If you have any further questions, please ask Dr.Augustin Abraham.T, Dr. Rohin Mittal or
Dr. Mark Ranjan Jesudasan (tel: 0416 2282159/ 2282120/ 2282207) or email:
augustin.t@cmcvellore.ac.in
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Consent form
CONSENT TO TAKE PART IN A CLINICAL TRIAL
Study Title:
Does Normal saline wound irrigation help in preventing post operative surgical site
infection?
Study Number:
Participant’s name:
Date of Birth / Age (in years):
I_____________________________________________________________
___________, son/daughter of  ___________________________________
(Please tick boxes)
Declare that I have read the information sheet provide to me regarding this study and have
clarified any doubts that I had. [ ]
I also understand that my participation in this study is entirely voluntary and that I am free
to withdraw permission to continue to participate at any time without affecting my usual
treatment or my legal rights [ ]
I also understand that neither I, nor my doctors, will have any choice or knowledge of
whether I will get Normal saline wound irrigation or not [ ]
I understand that I will receive free treatment for any study related injury or adverse event
but I will not receive and other financial compensation [ ]
I understand that the study staff and institutional ethics committee members will not need
my permission to look at my health records even if I withdraw from the trial. I agree to this
access
[ ]
I understand that my identity will not be revealed in any information released to third
parties or published [ ]
I agree to pay for any investigation routinely warranted for my treatment [  ]
I voluntarily agree to take part in this study [ ]
Name:
Signature:
Date:
Name of witness:
Relation to participant:
Date:
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EPI DATA SHEET
Variable name         Label                <IDNUM>
sno S.No.          Study No.                   ###
DOE            Date of enrollment          <dd/mm/yyyy>
Name           Patient's name ______________________________
Age            Age in years                ##
Sex            Gender                      #(1-Male, 2-Female)
ID no.         Hospital No.                ######
Contact no.    Mobile No. ############
Address        Residential                 ________________________________________
address1
________________________________________
address2
________________________________________
Wt             In Kg                       ###
Ht             In cm                       ###
BMI            Wt/Ht2                      ##.##
Pre-op
PDx           Primary Diagnosis           ______________________________
CA            carcinoma                    # (1-present, 2-absent)
DM             Diabetes Mellitus           #(1-yes,0-No)
ht1 HT             Hypertension                #(1-yes,0-No)
Hb             Anaemia(Less than 10g%) #(1-yes,0-No)
Alb            Hypoalbuminemia             #(1-Less than 1.5g%,2-1.5 to 3,3-More
than 3.1)
ImmS           On immunosuppressants       #(1-yes,0-No)
CRT            Chemoradiation therapy      #(1-Given,0-Not given)
Stoma          Presence of stoma           #(1-Present,0-Absent)
Operation      Operation performed
__________________________________________________
Type           Type of operation           #(1-Elective,2-Emergency)
INTRA-OP
Sur            Surgeon #(1-Consultant,2-PG trainee)
Antibiotics    Pre-operative antibiotics   #(1-Yes,2-No)
Skin Prep      Skin preparation            #(1-Chlorhexidine,2-Povidone Iodine)
Incision       Vertical/Horizontal         #(1-Transverse,2-Vertical)
116
LOI Length of incision          #(1-More than 7cm,2-Less than 7cm)
IOPCon         Int-operative contamination #(1-Yes,0-No)
Device         Wd prt device used          #(1-Yes,0-No)
DuOSx          Duration of surgery         #(1-Less than 3hrs,2-More than 3hrs)
Skincl         Skin closed                 #(1-Yes,0-No)
SuMat          Suture Material used        #(1-Staple,2-Ethilon,3-Monocryl)
Stmtr          Stoma trephined             #(1-Yes,0-No)
Post-op
Abx            Antibiotic used #(1-Yes,0-No)
If yes         If yes,What                 ______________________________
Cmpl           Postop complications        #(1-Yes,0-No)
if1 If yes         If yes,What                 ______________________________
Wound assessment till discharge
Symptoms:
Pn             Pain                        #(1-Yes,0-No)
Sg             Swelling                    #(1-Yes,0-No)
Dge            Discharge                   #(1-Yes,0-No)
if2 If yes         If yes,What #(1-Serosanguineous,2- Pus,3-Others)
Signs:
Wmth           Warmth                      #(1-Yes,0-No)
Tness          Tenderness                  #(1-Yes,0-No)
SR             Suture/Staple removed       #(1-Yes,0-No)
Wd             Wound Dehiscence #(1-Present,0-Absent)
Investigations:
Pus Cx         Pus culture                 #(1-Yes,0-No)
if3 If yes         If yes,What                 #(1-Significant growth,0-No growth)
RD             Radio Investigation         #(1-Done,0-Not done)
if4 If yes         If done,findings of deep    #(1-Yes,0-No)
incisional SSI/Abscess
reop Re-op          Re-operation                #(1-Yes,0-No)
if5 If yes         If yes,evidence of deep     #(1-Yes,0-No)
incisional SSI/Abscess
Dx             Dx by Surgeon               #(1-Infection present.2-Infection
absent)
Wound assessment at 1st OP visit
Symptoms:
117
pn1 Pn             Pain                        #(1-Yes,0-No)
sg1 Sg             Swelling                    #(1-Yes,0-No)
dge1 Dge            Discharge                   #(1-Yes,0-No)
if6 If yes         If yes,What                 #(1-Serosanguineous,2- Pus,3-Others)
Signs:
wmth1 Wmth           Warmth #(1-Yes,0-No)
tness1 Tness          Tenderness                  #(1-Yes,0-No)
sr1 SR             Suture/Staple removed       #(1-Yes,0-No)
wd1 Wd             Wound Dehiscence            #(1-Present,0-Absent)
Investigations:
pus1 Pus Cx Pus culture                 #(1-Yes,0-No)
if7 If yes         If yes,What                 #(1-Significant growth,0-No growth)
rd1 RD             Radio Investigation         #(1-Done,0-Not done)
if8 If yes         If done,findings of deep    #(1-Yes,0-No)
incisional SSI/Abscess
reop1 Re-op          Re-operation                #(1-Yes,0-No)
if9 If yes         If yes,evidence of deep     #(1-Yes,0-No)
incisional SSI/Abscess
dx1 Dx             Dx by Surgeon               #(1-Infection present.2-Infection
absent)
Wound assessment at 1st month
Symptoms:
pn2 Pn             Pain                        #(1-Yes,0-No)
sg2 Sg             Swelling                    #(1-Yes,0-No)
dge2 Dge            Discharge                   #(1-Yes,0-No)
if10 If yes         If yes,What                 #(1-Serosanguineous,2- Pus,3-
Others)
Signs:
wmth2 Wmth           Warmth                      #(1-Yes,0-No)
tness2 Tness Tenderness                  #(1-Yes,0-No)
sr2 SR             Suture/Staple removed       #(1-Yes,0-No)
wd2 Wd             Wound Dehiscence            #(1-Present,0-Absent)
Investigations:
pus2 Pus Cx         Pus culture                 #(1-Yes,0-No)
if11 If yes         If yes,What                 #(1-Significant growth,0-No growth)
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rd2 RD             Radio Investigation         #(1-Done,0-Not done)
if12 If yes         If done,findings of deep    #(1-Yes,0-No)
incisional SSI/Abscess
reop2 Re-op          Re-operation                #(1-Yes,0-No)
if13 If yes         If yes,evidence of deep     #(1-Yes,0-No)
incisional SSI/Abscess
dx2 Dx             Dx by Surgeon               #(1-Infection present.2-Infection
absent)
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DATA SHEET
variable sno doe name age sex id contact address address1 address2 wt ht bmi n1 dm ht1 hb alb
1 1
23/12/201
2 Dipu Rani Das 57 2 276207 7.5E+09 East GomaDandi Iqbal park Bangladesh 61 156 25.07 Adenocarcinoma rectum pT2N1M0 1 1 2 3
2 2
23/12/201
2 Fathima Edwin 68 2 677751
4.16E+1
0 119E,Vallalar nagar, Bagayam Vellore-632002 43 150 19.11 Loc. adv.Ca asc colon ypT3N2M1 1 1 1 3
3 3
06/01/201
3 PAYOOR PAUL JOHN 63 1 303908
9.89E+0
9
KN/34,NOAH'S ARK,KAIRALI
NAGAR,MANNANTHO THIRUVANANTHAPURAM KERALA-695015 80 167 28.7 ADENOCA  RECTUM ypT2NOMO 0 1 0 3
4 4
09/01/201
3 SAROJDAS 50 2 286035 E.E. NAHARLOGUN DIVN. APART. PWD NAHARLAGUN PAPUM PARE ARUNACHAL PRADESH-791110 60 161 23.1 ADENOCA RECTUM ypT3N2bM0 1 0 0 3
5 114
13/01/201
3 ELUMALAI.M 24 1 287766
9.94E+0
9 KANIKAPURAM, PACHIAMBADI POLUR THIRUVANNAMALAI TAMIL NADU 46 160 18
ADENOCA RECTUM
SM/ALCOypT3N0M0 0 0 0 3
6 5
20/01/201
3 JOSEPH TSHERING LEPCHA 74 1 293908
9.43E+0
9 SICHEY/ GANGTOK GANGTOK EAST SIKKIM SIKKIM - 737101 64 164 23.8
ADENOCA RECTOSIGMOID
T4bN1bM1 0 0 1 3
7 6
23/01/201
3 ANISUZZAMAN.M.DR 48 1 377639
1.72E+0
8 167, BOSEPARA, GHORAMARA RAJSHAHI BANGLADESH 60 166 21.8 CA RECTOSIGMOID SMO T4N2M0 0 1 0 3
8 7
30/01/201
3 UTTAM SHIT 22 1 300302
7.87E+0
9 EKARUKHI BARABATIA EAST MIDNAPORE WEST BENGAL - 721443 180 71 26 Adenoca rectum ypT3N0M0 0 0 0 0
9 8
14/02/201
3 MOSAMAD MOMTAZ AZHAR 14 2 397219 8.8E+09 C/35, COLLAGE PARA BHALUKA MYMENSINGH BANGLADESH 78 157 31.6 AdenoCa sigmoid colon pan 1 0 0 0
10 9
17/02/201
3 VENKATA SANDEEP 14 1 823003
9.85E+0
9 QUARTER NO 328/B/A/3 SECTOR 3 UKKUNAGARAM, VISAKHAPATNAM ANDHRA PRADESH -500032 25 145 11.9 Crohn's,ileal stric, gwth rtdn 0 0 0 0
11 10
24/02/201
3 MAKHAN SARKAR 51 1 290225
9.64E+0
9 BHERPARA TENGHA MARI, DHUPGURI JALPAIGURI WEST BENGAL - 735210 54 155 22.1 Squamous cell Ca T3NO 0 0 0 0
12 11
27/02/201
3 SADDAM HUSSAIN 20 1 335922
9.83E+0
9 MAGRAHAT 24 PARGANAS SOUTH WEST BENGAL 55 167 19.7 ADENOCA RECTUM 0 0 0 0
13 12
01/03/201
3 SABITRI CHAKRAVORTY 44 2 423528
9.95E+0
9 BAKAITARY VILL MATIA GOALPARA ASSAM - 783125 40 152 17.3 CARCINOMA HEPATIC FLEXURE 0 0 1 3
14 13
16/03/201
3 Purabi Paria 33 2 251059
9.79E+0
9 NAMADIHA PURBU MIDNAPUR WEST BENGAL - 721444 40 154 16.9 AdenoCA rectum withB/l TO mass 0 0 0 2
15 14
01/04/201
3 Jameela K M 62 2 368898 707A,MUNDUHUMAKKAL HOUSE MAMANGALAM ERNAKULAM - 682025 58 150 25.8
CA RCTM INF SACRM&VAG POST
LC 1 0 0 3
16 15
03/04/201
3 Pallabhi Hui 22 2 444551
9.61E+0
9 MOGLANI CHAK DHANESWARPUR WEST, MIDNAPORE WEST BENGAL - 721166 54 149 24.3 Metastatic trans colon Ca 0 0 0 0
17 16
06/04/201
3
RAMESH CHANDRA RAY
MOHAPATRA 57 1 443909
9.44E+0
9 QTR K101, HAL TOWNSHIP SUNABEDA 2 KORAPUT ORISSA - 763002 65 175 21.2 Ca sig co with blddr infil 8/4 1 1 0 1
18 17
06/04/201
3 Mamta Kumari 29 2 416650
9.93E+0
9 ChasBokaro Jharkhand -827012 43 150 19.1 Ileo-caecal Tuberculosis 0 0 1 3
19 18
06/04/201
3 Jarapala Ramesh Naik 17 1 444493
9.54E+0
9 A.B. PALLI THANDA MUDIGUBBA ANANTHAPUR ANDHRA PRADESH - 515511 48 164 17.8 Ca sigm infil abd wall T3N1M0 0 0 1 3
20 115
13/04/201
3 Singrai Murmu 47 1 449643
9.55E+0
9 JAMIRDIHA PACHMI, MIDNIPUR WB - 785412 36 150 16 Caecal carcinoma 0 0 1 0
21 19
13/04/201
3 AYISHA M.P.M. 35 2 352040
9.85E+0
9 FAROOK COLLEGE ROAD RAMANATTUKARA KOZHIKODE, KERALA - 673632 48 152 20.8 Ulcerative colitis 0 0 0 3
22 20
16/04/201
3 Chandra Maya Nepali 55 2 436088
9.79E+0
9 GAISAR ITAHARI SUNSARI, NEPAL 70 151 30.7 Ca rctal stmp post Hartmann's 0 0 0 0
23 21
20/04/201
3 P.G.Mathai 63 1 363342
8.75E+0
9 Variya veedu, Kizake theruvu street,Kottarakara Kollam - 691531 66 176 21.3 Adenocarcinoma rectum 0 1 0 3
120
24 22
27/04/201
3 Bidhan Chandra Biswas 49 1 447918 9.9E+09 SARODAMAYEE LANE THAKURPARA PURBAPUTIARY, RIGENT PARK
24 PARGANAS SOUTH,WEST BENGAL-
700093 56 170 19.4 Obstructed Carcinoma sigmoid 0 0 0 3
25 116
11/05/201
3 Ponnurangam 61 1 466911
9.79E+0
9 1/26 PILLAIYAR KOIL ST. VANJUR, SENUR KATPADI VELLORE - 632006 67 173 22.4 Carcinoma sigmoid colon 0 0 0 0
26 117
19/05/201
3 Goutam Gayen 36 1 428941
7.42E+0
9 DABU CANNING SOUTH 24 PARGANAS WB-743329 60 165 22
CAECAL POLYP WITH HIGH GDE
DYS 0 0 0 3
27 118
19/05/201
3 Nuni Bala Debi 46 2 368817
8.87E+0
9 MIRDHA SARDAHA BOKARO WB-827013 40 145 19
CA RECTUM POST LCCRT STMAL
PRO 0 0 0 3
28 23
19/05/201
3 Haidar Ali 50 1 418912
9.66E+0
9 ILAM,ROSALPUR CHANCHAL MALDA WB-732123 71 171 24.3 ILEAL THICKENING ?LYMPHOMA 0 1 1 3
29 24
22/05/201
3 Rajeshwara Rao 66 1 466297 9.4E+09 70-12-5  N S M  SCHOOL ROAD SANTI NAGAR PATMATA, VIJAYAWADA KRISHNA,AP 65 165 23.9 CA DESCENDING COLON 1 1 0 3
30 25
25/05/201
3 Brojan Dronath 50 1 318204
1.75E+0
9 VARSHO WB-1710 57 165 20.9 Cs rectum 0 0 0 3
31 26
25/05/201
3 Md Abdul Kaiom Sheikh 41 1 472702
9.85E+0
9 BORO BHODEYAGURI BHOTGAON KOKRA JHAR ASSAM 53 158 21.2 CARCINOMA CAECUM 1 0 0 2
32 27
29/05/201
3 Sk. Anwar Basha 41 1 453816
9.89E+0
9 3/555, CUDAPPA ROAD L.R.PALLI CUDDAPAH AP-516257 55 165 20.2 Ca sig wth SI&UB infil 30/5/13 0 0 0 0
33 28
01/06/201
3 Reethamma 61 2 405742 1E+10 PRANAVAM, KUREEPUZHA KOLLAM KERALA - 691003 63 152 27.3 CARCINOMA RECTUM POST LCCRT 0 1 0 3
34 29
09/06/201
3 Baby Mishra 21 2 437967
9.61E+0
9 PALASH BON,BAKTAR NAGAR ANDAL BARDHAMAN WB-713321 45 159 17.8 CONG MEGACOLON - POST PULL 0 0 0 3
35 31
16/06/201
3 Essakkithai 58 2 839842
9.89E+0
9 17,NORTH ST.,VELANPUTHUKULAM SATTANKULAM, TUTICORIN TAMIL NADU - 625704 49 153 20.9
STATUS TRANS COLOSTOMY+SIG
STR 0 0 0 0
36 30
19/06/201
3 Ram Dip Pandey 62 1 746205
9.33E+0
9 278,A,PRASAD FLOOR MILL ROAD NEAR NEW A G COLONY,DORANDA RANCHI JHARKHAND - 834002 64 167 22.9 Ca sigmoid with lung mets 0 0 0 3
37 32
01/07/201
3 JAHURUL HOQUE MOLLA 71 1 488944
9.83E+0
9 AMGACHIA 24 PARGANAS SOUTH WEST BENGAL - 700104 58 160 22.7 SIGNT RNG CELL CA RECpT2N2M0 0 1 0 3
38 33
10/07/201
3 Sundaram 63 1 104899
9.95E+0
9 11/1 KANMANI ST SRIRAM NAGAR, SATHUVACHARI VELLORE - 632009 38 162 14.5 PERF SIG COLON CARCINOMA 0 0 1 2
39 34
14/07/201
3 JITENDRA NARAYAN SINGH 43 1 238345
8.76E+0
9 Q.NO.20 3 /D BOKARO STEEL CITY, CHAS BOKARO JHARKHAND - 827003 67 165 24.6 CA HEPFL ST RT HMICOL MET TC C 0 1 0 3
40 35
14/07/201
3 Syed Murshid Ahmed 43 1 355793 7.6E+09 166 LAL MOHAN SHAFI ST SADAR SUTRAPUR DHAKA BANGLADESH 54 174 17.8 Carcinoma rectum post LCCRT 0 0 0 3
41 36
21/07/201
3 Chaina Chakraborty 56 2 120024 7.5E+09 BACITERA, MARELIA ADRA PURULIYA WB - 723121 45 147 20.8 S/P HRTMAN'S+PROX STRIC ?BCC 0 0 0 3
42 39
21/07/201
3 Tahira Bibi 34 2 449348
8.94E+0
9 GOPALPUR MURSHIDABAD WB - 742304 56 164 20.8 CARCINOMA RECTUM POST LCCRT 1 1 1 3
43 40
24/07/201
3 Rajeshwari 66 2 467496
9.63E+0
9 41, LAKSHMIPURAM GANDHINAGAR, KATPADI, VELLORE TAMIL NADU -632006 71 160 27.7 AdenoCA hep flexure and cecum 0 1 1 3
44 42
03/08/201
3 Pracheta Ranjan Chaulya 31 1 447689
9.65E+0
9 MONOHARPUR
NARAYANBARH, KHARAGPUR WEST
MIDNAPORE WB - 721144 50 164 18.6 CA rectum post LCCRT 0 0 0 0
45 43
03/08/201
3 Bandana Das 50 2 463585
9.79E+0
9 TILKURIA MOHISGORIA BURDWAN WB - 712402 29 137 15.5 Ca rectum 0 0 0 0
46 41
08/08/201
3 Santhosh Sen 45 1 491569 8.9E+09 BHURI BURDWAN WB - 713432 36 170 12.5 Trans colon stricture ?TB 0 0 0 3
47 45
11/08/201
3 Sathiyamoorthy 44 1 418984
9.94E+0
9 2/31, KOTTAI VEEDI PERIYANKUPPAM VANIYAMBADI VELLORE-635814 74 173 24.7 CARCINOMA RECTUM post LCCRT 0 0 0 0
48 46
18/08/201
3 Debashis Guha 45 1 441372 8.1E+09 WEST KAMAR THUA HABRA, AKRAMPUR NORTH 24 PARGANAS WB - 743263 47 152 20.3 Ca rectum T4N2M0 0 0 0 3
121
49 47
18/08/201
3 MD. Tofassal Hossain 62 1 468398
9.57E+0
9 DILALPUR NAGESWARPUR,OLD MALDA MALDA WB - 732142 64 163 24.1 Carcinoma rectum 1 1 0 3
50 48
25/08/201
3 Khaleda Begum 40 2 633129
1.81E+0
9 FATHEHABAD CHITTAGONG BANGLADESH 54 155 22.5 Retro rectal lipoma 1 0 0 0
51 49
25/08/201
3 Harinder Mahto 38 1 640912
9.52E+0
9 KUNUSTORIA COLLIERY TOPOSI, JAMURIA BARDHAMAN WB - 713362 45 162 17.1 Tubercular stricture hep.flexu 0 0 1 3
52 50
25/08/201
3 Laxmi Rani Das 37 2 637425
9.16E+0
9 DEWAN PUR CHITTAGONG BANGLADESH 55 147 25.5 Carcinoma sigmoid colon 1 0 0 3
53 51
29/08/201
3 Kumar 59 1 430952
9.44E+0
9 31/18 RAMAN STREET PERNAMBUT, GUDIYATTAM VELLORE TAMIL NADU 59 157 23.9 RECTAL CARCINOMA - POST LCCRT 1 1 0 3
54 52
28/09/201
3 Bela Sarkar 33 2 477345
9.43E+0
9 PRANTA PALLY Malda WB - 732101 39 150 17.3 Carcinoma rectum 0 0 0 3
55 54
05/09/201
3 Dolan Chandra Hazari 48 1 649464
9.86E+0
9 NIZ BANGAON THELAMARA SONITPUR Assam - 784149 49 153 20.9 CARCINOMA ASCENDING COLON 1 0 1 2
56 56
08/09/201
3 JeyaKrushna Jena 49 1 484875
9.79E+0
9 MAYUR BHANJ, BARIPADA R.G. PUR MAYURBHANJ ORISSA - 757020 61 162 23.2 Carcinoma rectum post LCCCRT 0 0 0 0
57 57
08/09/201
3 Sandhya Barman 58 2 658515
9.88E+0
9 148/A RAIL PLOT DANGAPARA KANCHRAPARA, NORTH 24 PARGANAS WB - 743145 55 125 35.2 Perforated CA sigmoid 0 0 1 2
58 55
18/09/201
3 Susamma George 56 2 670287
9.94E+0
9 KALAR VILAYIL HOUSE
MALLASSERY, KOZHENCHERRI
PATHANAMTHITTA KERALA - 689646 78 167 28.8 CA HEPATIC FLEXURE COLON 1 0 1 3
59 58
21/09/201
3 Theresemma 70 2 411640
9.45E+0
9 KADAMPAZHI PURAM OTTAPALAM PALAKKAD KERALA - 678633 85 155 35.4 CA rectum 1 1 0 0
60 59
24/09/201
3 Renji Daniel 44 1 665409
9.89E+0
9 FLAT NO. FS4,
KIMATARA MAGAN RICE, OPP RAGAVENDRA
TEMP
ULIMAVU MAIN ROAD, BANGALORE -
560076 59 170 20.4 Ca asc.colon 0 0 1 3
61 60
28/09/201
3 Joydev Bhowmick 24 1 387301
8.14E+0
9 Amlat HALDIA EAST MIDNAPORE WB - 721645 63 163 23.5
CA RECTUM - POST
CHEMO&LCCRT 0 0 0 0
62 61
28/09/201
3 Piyali Kundu 42 2 665399
9.66E+0
9 MANDALGANTHI, BAMAN GACHI 24 PARGANAS-NORTH WB - 704706 60 147 27.5 CARCINOMA RECTOSIGMOID 0 0 0 3
63 62
03/10/201
3 Shyamal Ghosh 39 1 600709 9.8E+09 SRI RAM PUR,PATULI STATION BAZER BURDWAN WB - 713512 52 172 17.6 CA RECTUM POST LCCRT 1 0 0 3
64 63
03/10/201
3 Aditya Bangal 48 1 683149
9.66E+0
9 BARKOLA, PALASBONI BISHNUPUR BANKURA WB - 722157 42 173 14 CA ASCENDING COLON 0 0 0 3
65 64
06/10/201
3 Molly 58 2 424325 9.9E+09 THADIKUZHINGARA ULLAS NAGAH, KANJIKODE WEST,PALLAKAD KR - 678623 60 155 35 MUC. ADENOCA- APPENDIX POFT 0 0 0 3
66 65
07/10/201
3 Jahangir Mondal 46 1 478651
8.22E+0
9 AMDANGA NORTH 24 PARGANAS WB- 743221 43 160 16.8 CARCINOMA CAECUM 1 0 0 3
67 66
07/10/201
3 Jharna Bagal 42 2 484083
8.65E+0
9 SALIKHA GIDHRI WEST MIDNAPORE WB - 721505 40 145 19 CARCINOMA RECTUM POST LCCRT 0 0 1 3
68 67
10/10/201
3 Geetanjali Behera 58 2 682871
9.34E+0
9 NDIA EVERY HOME CHRSADE CUTTACK SADAR CUTTACK ORISSA - 753001 50 147 23.1
METASTATIC ASCENDING COLON
CAR 1 1 1 3
69 68
16/10/201
3 Ram Naresh Singh 64 1 672740
9.39E+0
9 BARTAND DHANBAD JHARKHAND - 826001 59 172 19.9 Ca asc.colon,liver mets,int.ob 0 0 0 3
70 69
20/10/201
3 Ezra Prashanth 31 1 843482
9.89E+0
9 2/19  CSI COMPOUND CUDDAPPAH ANDHRA PRADESH -516001 87 170 30.1 end sigmoid colostomy post tra 0 0 0 3
71 70
03/11/201
3 Rupan Seal 33 1 678896
9.87E+0
9 UNSHOTTORPARA CHITTAGONG BANGLADESH 73 171 25 CA SIGMOID 0 0 0 3
72 72
20/11/201
3 Indrapal Singh 38 1 663841 9.2E+09 SHIVALIK APPARTMENT FLAT,8,RD-13, VIDHYANAGAR, HAVELI PUNE MAHARASHTRA-411032 41 165 15.1 ULCERATIVE COLITIS WITH STRICT 0 0 0 2
73 73
24/11/201
3 Subba Lakshmi 65 2 188225 8.1E+09 28-572 GANGAN PALLI CHITTOOR AP-517004 60 150 26.7 Sig diverticular stricture 1 0 0 3
122
74 74
12/12/201
3 Chittaranjan Thakur 65 1 744035
9.66E+0
9 Jharkhand 57 165 20.9 Ca cecum 0 0 1 3
75 75
15/12/201
3 CHITYA RANJAN MALLICK 45 1 683745
9.18E+1
1 WB 39 163 14.7 Colovesical fistula 0 0 0 3
76 76
15/12/201
3 Jagdish Chandra Das 57 1 659010
9.62E+0
9 UDAIPUR GOMATI
EST  BANK  AMAR SAGAR,
RADHAKISHOREPUR Tripura - 799120 45 156 18.5 Carcinoma rectum post LCCRT 0 0 0 3
77 77
01/01/201
4 Md. Abdus 61 1 746976
8.22E+0
9 01 ,01 , BLOCK B ,RULBARIA UTTARA DHAKA 61 164 22.7 Recurrent Carcinoma rectum 1 1 0 3
78 79
12/01/201
4 Nithyanandham 57 1 641563
9.09E+0
9 718,  PAZHAYA THATRA STREET, DEVIGAPURAM,ARNI TIRUVANNAMALAI TamilNadu -606902 85 165 31.2 CA rectum 0 0 0 3
79 80
12/01/201
4 Bidyut Dutta 40 1 499768 9E+09 TULIN PURULIA,New street, BAGHMUNDI PURULIYA WB-723212 77 165 28.3 CA rectosigmoid 0 0 0 3
80 81
19/01/201
4 Mani Achari 37 1 668224
8.94E+0
9 V. V. KANDRIGA KODUR CUDDAPAH AP-516101 80 175 26.1 FAP 0 0 0 3
81 82
26/01/201
4 Jagdeeshwara Rao 38 1 787682
8.94E+0
9 15-36, KANTUGUTTA STREET VIZIANAGARAM AP-535002 63 173 21 Ca trans colon,anal polyp,HBV 0 0 0 3
82 83
30/01/201
4 Rajamma Cheriyan 60 2 689858 8.3E+09 ALAKKODE KANNUR KERALA 87 155 36.2 CA rectum post LCCRT 0 1 0 3
83 85
02/02/201
4 Malati Pakharin 43 2 781639
8.22E+0
9 201 BLK 17  MIG  BLD UTTORAYON VILLAGE SILIGURI POST DARJEELING,WB 52 149 23.4 Lap subtotal colectomy 3/2/14 0 0 0 3
84 86
02/02/201
4 Ranganathan 65 1 358561
9.94E+0
9 BIG ST, SANTHAMPAKKAM VIL. & POST WALAJAH,VELLORE TN Status colostomy ileocecal gan 0 0 0 3
85 88
02/02/201
4 Jai Deo Ram 47 1 784401 9.6E+09 BAIHARI ORIA HAZARIBAG JHARKHAND -825303 60 172 20.3 CA asc.colon 0 0 1 2
86 84
09/02/201
4 Elsamma John 61 2 769275
9.84E+0
9 79/32 K.H ROAD NUNGAMBAKKAM CHENNAI - 600034 72 162 27.4 Ca rectum, 0 0 0 3
87 89
12/02/201
4 Most Nargis Begum 58 2 686194 8.8E+11 UTTAR JOYPURHAT DURGATOLI HAT,  JOYPURHAT BANGLADESH 50 158 20 Carcinoma rectum post LCCRT 0 0 0 3
88 91
23/02/201
4 Alpana Kundu 30 2 806189
8.88E+0
8 SRINAGAR PALLY,09732025800 BENACHITY DURGAPUR BURDWAN,WB 45 151 20 PNST hepatic flexure 0 0 1 3
89 93
02/03/201
4 Rahil Topno 58 2 728434
9.94E+0
9 PARSUDIH CHRISTIAN BASTI TATANAGAR EAST SINGHBHUM JHARKHAND - 831002 42 152 18.2 CA rectum and cervix 0 1 0 3
90 92
05/03/201
4 Rammurat Jaiswal 47 1 761127
9.84E+0
9 BIRSANAGAR, ZONE NO. 1 B
GOBINDH PATH, DHALBHUM JAMSHEDPUR
EAST S JHARKHAND -831004 50 170 17.3 Recurrent rectal prolapse 0 0 0 0
91 94
08/03/201
4 Monoj Kr Sarkar 23 1 609212
8.49E+0
9 RAHIM PUR BUNIADPUR DINAJPUR-NORTH WB 53 165 19.5 Hrschsprng's dse post ileostom 0 0 0 0
92 95
16/03/201
4 MALOTI DAS 42 2 724368
8.51E+0
9 PUMLIA CHAKDAH NADIA WB-741222 54 147 25 Carcinoma rectum post LCCRT 0 0 0 3
93 97
16/03/201
4 Sumita Maji 36 2 814270
9.78E+0
9 BOLURI, SUPAPURSURI MIDNAPORE MEDINIPUR-WEST WB 37 148 16.9 CA descending colon 0 0 0 3
94 96
19/03/201
4 MahaLakshmi 53 2 858844
9.17E+0
9 298 ARNI ROA, VIRUPAKSHIPURAM VELLORE TN 83 156 34.1 CA transverse colon 1 0 0 3
95 98
23/03/201
4 Subramaniyan 61 1 807788
9.75E+0
9 3/57,  CHINNAKALIPALAYAM IDUVAI, TIRUPUR TN - 641687 63 162 24 CARCINOMA SIGMOID COLON 0 0 0 3
96 99
30/03/201
4 Sabita Byapari 41 2 808575
8.16E+0
9 KAMARTHUBA HABRA NORTH 24 PARGANAS WB-743263 48 152 20.8 CA LEFT COLON 0 0 1 3
97 100
30/03/201
4 Arulmani 61 2 740329
9.44E+0
9 Villupuram 50 150 22.2 CA left colon 1 1 1 2
98 101
06/04/201
4 Rafique Ahamad 43 1 799439
8.97E+0
9 KAETIA BURDWAN BARDHAMAN WB-713102 73 158 29.2 CA cecum 0 1 0 0
123
99 102
12/04/201
4 Gaffar Ali Mondal 56 1 786541
9.83E+0
9 RAJPUR BARANDA PARA SOUTH 24 PARGANAS WB-700149 46 150 20.4 FAP 0 0 0 3
100 104
12/04/201
4 Antony Dorai 81 1 621947
9.44E+0
9 C-35 BHEL NAGAR REC PO TRICHY-620 015 71 166 25.8 CA rectum 0 0 0 3
101 106
20/04/201
4 Sribas Maity 59 1 722315 9.8E+09 DHARAMPUR, CHOUTAR BANKURA WB -722210 65 165 23.9 Rectal GIST 0 0 0 3
102 103
26/04/201
4 Sarbani Makal 25 2 774839 9.6E+09 SANKARAIL HOWRAH HOWRAH WB-711313 41 146 19.2 CA RECTUM POST LCCRT 0 0 0 3
103 107
30/04/201
4 Selvaraj 58 1 837967
9.63E+0
9 TOWN STREET ULLIPUDHUR, KATPADI, VELLORE TN-632106 57 174 18.8 CA rectum 0 0 0 3
104 105
04/05/201
4 Nadeem Ahamad 40 1 839393
9.61E+0
9 LANE MOHALLA, DORANDA Ranchi Jharkhand - 834002 63 180 19.4 CARCINOMA ILEUM 0 0 0 3
105 108
08/05/201
4 Lutmon Lynshiang 54 2 839744
9.86E+0
9 LUMPARING, LABAN EAST KHASI HILLS MEGHALAYA INDIA - 793004 42 145 20 Hepatic flexure carcinoma 0 0 1 3
106 109
07/05/201
4 VijayaBaskar 37 1 780237
9.95E+0
9 DOOR NO:29 AMBETHKAR BRANCH ST' KALIZUAR, KATPADI VELLORE TN-632006 39 173 13.5 CARCINOMA DESCENDING COLON 0 0 0 2
107 111
10/05/201
4 JoyShree Roy 23 2 780237
8.88E+0
9 WARD NO-2, HAILAKANDI TOWN HAILAKANDI ASSAM - 788151 42 145 20 Ca rectum LCCRT 0 0 0 0
108 112
10/05/201
4 Deben Borah 60 1 272148
9.09E+0
8 POKAMURA JORHAT ASSAM-785009 53 154 22.3 CA asc. colon 0 0 1 3
109 119
18/05/201
4 Sriivashini 30 2 840088
8.06E+0
9 36/1 SWARNA PUSHPAM COLONY,
VENKATESA
COLONY,POLLACHI,COIMBATORE TN-642001 49 170 17 SEVERE UC STEROID RESISTANT 0 0 1 1
110 120
18/05/201
4 Tarun Roy 44 1 847743
9.84E+0
9 AGARPARA
RAJA CHANDRA GHATAK RD.A. C LANE
KOLKATA WB-700149 42 162 16 CARCINOMA CAECUM 0 0 1 3
111 121
18/05/201
4 Ganga 54 1 842405
9.75E+0
9 162,NEW STREET, KIL VALLAM VILAGE KANNAMANGALAM POST VELLORE TN - 632311 52 156 21.4 METASTIC CARCINOMA CAECUM 1 1 1 3
112 123
25/05/201
4 Kalaivani 59 2 751274
9.89E+0
9 167/268 19TH CROSS STREET, TNHB, WALAJAPET TAMIL NADU 44 149 20.9 CA REC INF FUNDUS OF UTERUS 1 0 0 3
113 124
25/05/201
4 Md. Jaffar Hossain 53 1 854893
1.83E+0
9 Chittagong Bangladesh 55 171 18.8 Metachro Ca tr colon st R hemi 0 0 1 3
114 125
01/06/201
4 Pathipati Govinda Naidu 59 1 763137
9.97E+0
9 ANDHRA PRADESH 72 172 24.3 Ca rectum 0 0 0 2
115 126
01/06/201
4 Rafael Golmes 68 1 765355
8.88E+0
8 Bangladesh 63 169 22.1 Ca rectum 1 1 0 3
116 110
10/05/201
4 Alok Dey 51 1 775589
9.57E+0
9 WB 58 175 18.9 CA rectum 0 1 0 3
117 127
09/06/201
4 Rajkumar Bijoy Singh 71 788887
9.44E+0
9 Manipur 65 165 23.9 CA RECTUM POST LCCRT PHIMOSIS 0 0 0 3
118 128
16/06/201
4 Pradip Dey 51 1 862616
9.36E+0
9 B'desh 53 155 22.6 Ca sig colon 1 1 0 3
119 129
16/06/201
4 John SunderRaj 67 1 819889
9.72E+0
9 Attur Salem TN 78 165 28.7 CA rectum 0 1 0 3
121 131
16/06/201
4 Shibani Sarkar 24 2 806825
9.43E+0
9 WB 55 153 23.5 Ca rectum 0 0 0 3
122 132
18/06/201
4 Bandana Mishra 46 2 902514
9.48E+0
9 WB 39 155 16.2 Rectal prolapse 0 1 1
123 133
18/06/201
4 Chiranjevi Jha 62 1 852395
8.29E+0
9 Jharkhand 68 175 22.2 CAcaecum 0 0 0 3
124 135
18/06/201
4 Sadhana Halder 59 2 822583
8.01E+0
9 WB 63 148 28.8 CArectum 0 0 1 3
124
125 136
22/06/201
4 Padmini 53 1 683167 TN 55 150 24.4 CA rectum 0 1 0 3
126 137
22/06/201
4 Salma Bibi 31 2 858150
9.63E+0
9 WB 37 147 17.1 Synchronous colon CA 0 0 1 3
127 138
22/06/201
4 Bishwanath Biswas 42 1 857935
9.83E+0
9 WB 48 155 20 CA asc colon 0 0 1 3
128 139
29/06/201
4 Sampa Kotal 26 2 910222
9.73E+0
9 WB 46 160 18 Ileocecal mass ?Crohn's 0 0 0 2
129 140
29/06/201
4 Yesu Babu 47 1 874936 9.7E+09 AP 60 163 22.6 CA asc colom 1 1 1 3
130 141
06/07/201
4 Arun Saha 20 1 871563
7.42E+0
9 WB 82 155 34.1 CA rectosigmoid 0 0 0 0
131 143
06/07/201
4 Sumithra Subba 37 2 891833
9.55E+0
9 WB 65 157 26.4 CA asc colon 0 0 1 3
132 144
06/07/201
4 Raju Baidya 23 1 891388
9.38E+0
9 WB 47 163 17.7 Ileocecal Crohn's disease 0 0 0 3
133 142
09/07/201
4 IraBera 40 2 834853
8.94E+0
9 WB 45 148 20.5 CA rectum 0 0 0 3
134 145
09/07/201
4 Baiju Varghese 50 1 879933
9.85E+0
9 Kerala 64 175 20.9 CA sig COLON 1 0 0 3
135 146
20/07/201
4 DhanaRangan Sharma 36 1 825162
7.67E+0
9 Bangladesh 621 156 26.5 CA Rectum 1 0 0 3
136 147
20/07/201
4 Arjit Mridha 22 1 453685
7.67E+0
9 WB 51 169 17.9 CA rectum 0 0 0 3
137 148
24/07/201
4 Radhesh Sharma 44 1 234213 9.6E+09 Bihar 54 163 20.3 CA rectum 0 0 0 2
138 150
11/08/201
4 Nirmal Khanra 47 1 825827 9.6E+09 WB 65 163 24.5 CA rectum 0 0 0 3
125
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